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Abstract 
Ero1 is an endoplasmic reticulum (ER) resident protein responsible for PDI 
oxidation in disulphide bond formation. Recent work has shown a link 
between Ero1 and Notch pathway proteins. We wished to see if the 
oxidative folding of notch was directly catalysed by the Ero-PDI pathway 
or if Ero1 was involved in transcriptional modulation of Notch signalling. 
Using western blot analysis, immunoprecipitation and immunofluorescence 
analysis we were able to characterise and localise relevant proteins within 
cells. The range of cell lines and conditions under which the Ero1 antibody 
2G4 were confirmed and extended.  
A novel link between Ero1 and Jagged1, a notch ligand was found. In 
immunoprecipitation studies Ero1α was able to retrieve Jagged 1 and the 
opposite was also true, with Jagged 1 pulling down Ero1α as well. This 
suggests a novel and important link between the Ero1 and the function of 
the notch signalling pathway. 
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1. Introduction 
In order for a living cell to function viably it must be able to successfully synthesise 
and secrete functional proteins. A critical part of a cell secreting a working protein is 
ensuring that correct protein folding takes place. Protein folding has attracted a large 
amount of research due to the association of protein misfolding in several types of 
diseases including ageing disorders, diabetes, cancer and cystic fibrosis (Dobson, 
2003). For example, nearly 90% of all patients of cystic fibrosis have mutations in the 
gene encoding for the cystic fibrosis transmembrane conductance regulator (CFTR) at 
position 508. The CFTR is an ion channel responsible for transport of chlorine and its 
loss of function leads to cystic fibrosis. CFTR undergoes a series of strict post 
translational modifications in the ER including, glycosylation and oligosaccharide 
chain modification, with only a 33% of all proteins produced being released from the 
ER in their native states. Mutation of the phenylalanine at position 508 completely 
blocks the maturation and export of the CFTR from the ER. This is believed to occur 
due to an altering of the binding site of the vesicle coat protein sec24 to the CFTR 
which prevents the CFTR from being exported from the ER by COP II vesicles 
(Riordan, 2008).  As well as cystic fibrosis, aggregation of proteins due to misfolding 
or mistranslation can cause diseases such as Huntington’s, Parkinson’s and 
Alzheimer’s (Vembar and Brodsky, 2008). 
 The endoplasmic reticulum (ER) is a highly specialised compartment within the cell 
which deals with a huge amount of protein maturation, including ensuring correct 
protein folding takes place (Helenius et al, 1992). To achieve this role the ER has 
evolved a large variety of molecular chaperones optimised to the role of protein 
folding. There are a huge variety of these chaperones in the ER, each with its own role 
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and function in ensuring proteins achieve their native state. Protein folding begins 
during synthesis as a vectorial process (Braakman & Bulleid, 2011) and is limited by 
the rate of protein transcription. Folding complexes compete with the protein itself to 
delay interactions within the protein, allowing the protein to be fully translated before 
it begins folding and prolonging the duration that the protein is in its less folded state. 
This helps prevent the protein from becoming misfolded before it has even been fully 
translated.  
 Posttranslational folding makes up the bulk of the work which is carried out by the 
ER. Research has provided a large list of proteins which have been shown to affect 
protein folding directly or that are assumed to have a folding role based on their 
structural similarities to other ER proteins. Examples of these proteins and their roles 
are wide ranging, and include Binding immunoglobulin protein (BiP) which has a very 
broad specificity and BiP helps maintain proteins in a optimal state for folding and the 
recruitment of co-chaperones. Other roles provided by ER proteins include glycan-
binding proteins like the Calnexin family of proteins, protein disulphide isomerases 
such as PDI and peptidyl prolyl cis/trans isomerases. Acting as folding catalysts, these 
chaperones ensure that unfolded polypeptides first achieve their correct tertiary 
structure and then later act as a quality control mechanism, ensuring only native folded 
proteins are produced by the cell (Hurtley and Helenius, 1989).  Enzymatic 
modification of proteins via carbohydrate addition and the formation or translocation 
of disulphide bonds occurs in the ER as a level of protein quality control (Sevier and 
Kaiser, 2008).  
If the folding of proteins is disrupted within a cell or the folding demand passes a cells 
capacity to fold proteins and misfolded proteins begin to build up in the ER the cell 
activates the unfolded protein response (UPR) (Ron and Walter, 2007) which causes 
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the cell to begin to produce more ER associated chaperone molecules, expand the ER 
lumen and increase the rate of removal of terminally misfolded proteins from the cell 
via ER-associated degradation (ERAD) (Cox et al, 1993). ERAD acts in three main 
capacities to ensure that any misfolded protein is removed from the cell. Molecular 
chaperones, such as the Hsp-70 family (Vembar and Brodsky, 2008), are able to bind 
to proteins which are to be targeted for ERAD. Detection of ERAD is dependent on 
factors such as exposed hydrophobic regions, the presence of immature N-linked 
glycans as recognised by UDP-glucose:glycoprotein glucosyltransferase (Caramelo et 
al, 2003) or failures in the protein folding, such as unpaired cysteine residues which 
can be recognised by complexes of PDI (see later) and BiP (Molinari et al, 2002). 
After being targeted for ERAD proteins are exported to the cytoplasm by the Sec61 
translocation channel and transported to the ubiquitin-proteasome system (UPS). The 
proteins are tagged for degradation by the 26S proteasome (Vembar and Brodsky, 
2008) via ubiquitination which is carried out by three types of enzyme, E1 ubiquitin-
activating enzyme, E2 ubiquitin-conjugating enzyme and E3 ubiquitin ligases.  These 
processes of ERAD act together in tandem to ensure that no misfolded or otherwise 
incorrect protein is able to leave the ER. 
One integral part of the protein folding process is the formation of disulphide bonds. 
Disulphide bonds are estimated to be involved in the formation of around one third of 
all human proteins (Hatahet and Ruddock, 2009) and are required for protein stability, 
regulation of protein activity and redox enzymatic function (Ellgaard et al, 1999).  A 
disulphide bond is a covalent link between two thiol (-SH) side chains on cysteine 
residues within polypeptides.  Reduction-oxidation (redox) reactions are reactions in 
which one chemical species attains a higher oxidation state via the loss of electrons or 
gain of oxygen, whilst conversely another species gains a lower oxidation state via the 
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gaining of an electron or loss of oxygen (Hatahet and Ruddock, 2009). Within thiol 
groups the sulphur has the oxidation state of -2 and when two groups are oxidised 
together to form a disulphide bond they are both lowered in oxidation state to -1. For 
this to occur, the reaction needs to lose two electrons and two protons to an oxidant, 
such as molecular oxygen. Any cysteine residue in a protein has the potential to form a 
disulphide bond with another, giving huge numbers of potential redox states and 
potential tertiary configurations for a protein, and yet most proteins have only a very 
select number of disulphide bond configurations in their native state. 
The classic experiments by Anfinsen et al (Anfinsen et al, 1963) showed that 
formation of disulphide bonds is a spontaneous process in vitro with only the 
polypeptide required in order to achieve its native state. However due to disulphide 
bond formation relying on a redox reaction, it is naturally a slow process and would 
also require an electron acceptor, such as oxygen, in vivo. These factors would suggest 
that disulphide linked folding must be an assisted process within the ER (Tu and 
Weissman, 2002). 
The first work identifying the proteins that assisted disulphide bond formation in the 
ER was undertaken by two groups during the 1960’s. Venetianer and Straub 
(Venetianer and Straub, 1963) found that they were able to reoxidise reduced 
ribonuclease with extracts from the pancreas of either chickens or pigeons. At the 
same time work by Anfinsen et al (Anfinsen et al, 1963) showed that microsomal 
systems from rat liver sped up the reactivation of ribonuclease. Later purification of 
the enzyme responsible showed it was able to catalyse thiol-disulfide exchange 
reactions and required a cofactor for its activity, which could be replaced by the 
addition of flavo adenine dinucleotide (FAD).  The enzyme discovered was named 
protein disulphide isomerase (PDI) and was the first folding catalyst reported. It is 
  Introduction 
5 
 
interesting to note that this work commented on a cofactor containing FAD, which was 
later named Ero1, nearly 30 years before it was fully characterised and found to be 
required for PDI activity. 
PDI is a 491 amino acid protein present in the ER in high concentrations and has a 
KDEL-ER retrieval motif (Pellham, 1990), marking it as an ER located protein.  PDI 
has a multidomain structure, with 4 distinct domains a, a’, b and b’ as well as a C-
terminal extension c (Hatahet and Ruddock, 2009). The a and a’ domains of PDI 
contain the catalytic domains of PDI, found at the N-terminus of the α2 helix whilst 
the b and b’ domains have been shown to be the principal binding sites of PDI 
(Klappa et al, 1998). 
PDI has been shown to have other roles within the cell, including acting as subunits of 
other protein complexes (Hatahet and Ruddock, 2009). For example, the P4HB gene, 
which codes for PDI has been linked with collagen formation. Here PDI acts as a 
subunit of a complex known as Prolyl 4-hydroxylase, which catalyses the formation of 
4-hydroxyproline residues that act to stabilise the triple helices seen in collagen 
structure (Pihlajaniemi et al, 2005). However, for my work I will focus on its roles in 
oxidative protein folding. 
PDI acts as an oxidant, containing a disulphide bond which is transferred over to a 
folding protein and thus becomes reduced to a dithiol state (Hatahet and Ruddock, 
2009). As mentioned above proteins have a huge number of potential configurations of 
disulphide bonds and free thiol groups, of which one will be its native state. Due to the 
random nature of protein folding, which could potentially bring any combination of 
cysteine residues together to form disulphide bonds, both native and non native state 
proteins can be found in the ER. Proteins fold rapidly with random thermal changes 
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leading the folding to move energetically towards the native structure, however the 
process is not perfect and non-native structures do occur (Dill and MacCallum, 2012). 
Thus the cell must be able to convert non native proteins into their native state. 
There are two potential pathways suggested to allow for these changes. The protein 
can either undergo a series of redox reactions, where the disulphide bonds are first 
reduced to their thiol state before being reoxidised in a new configuration, or undergo 
direct isomerisation. PDI can catalyse either of these reactions. PDI reacts with 
molecular oxygen slowly, meaning that all reactions catalysed by PDI must be thiol-
disulphide exchange reactions.  This gives PDI the potential to catalyse three types of 
reactions. 
The first type of reaction which PDI can support is an oxidation reaction.  This is done 
by losing one of the disulphide bonds from one of the active sites to a protein, causing 
a dithiol group on the protein to be oxidised to a disulphide state. To then finish this 
cycle PDI must be reoxidised. The reverse of this reaction is also catalysed by PDI, in 
which it reduces a protein disulphide bond to its dithiol state and in turn gains an 
active site disulphide bond itself. The PDI is then reduced to complete this cycle. 
Finally, in direct isomerisation PDI assists in the rearrangement of disulphide and thiol 
groups within a protein. This involves no change in the redox potential of the system 
and thus no extra reagents are needed. 
Before 1998 general opinion was that PDI was oxidised in vivo by reaction with 
oxidised glutathione (GSSG). However the discovery of the Endoplasmic Reticulum 
Oxidoreductin (Ero) family of proteins changed this, showing that GSSG is in fact a 
non functional by-product of the disulphide bond formation pathway. More recent 
work has shown that there is a complex interplay between reduced glutathione (GSH) 
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and Ero1 family members. GSH is responsible for the transfer of reducing equivalents 
from the cytosol into the ER (Molteni et al, 2004). Then GSH is oxidised to GSSG, 
forming a redox buffer to help maintain ER homeostasis.  
As mentioned above when Anfinsen et al (Anfinsen et al, 1963) first purified PDI, 
they found that a small low molecular weight molecule was also needed for PDI 
activity. The molecule was lost during dialysis but the function of PDI could be 
restored by adding FAD to the PDI, and was the first retrospective evidence of Ero 
activity. Frand et al (Frand et al, 1998) and Pollard et al (Pollard et al, 1998) were the 
first to report a homologue of this gene product, Ero1p, in S.cerevisiae as a molecule 
required for the formation of disulphide bonds in the ER. Homologues in many other 
eukaryotes were soon found.  
The Ero1 family are flavoproteins with two distinct di-cysteine active sites that act in 
the transfer of electrons from the substrate to the FAD molecule (Appenzeller-Herzog 
et al, 2008). One active site, the outer site, interacts and binds with the substrate whilst 
the second, inner site is next to the FAD molecule. The cysteine residues located on 
the outer site are able to move via a flexible polypeptide segment and shuttle electrons 
to the inner active site (Gross et al, 2004). 
Ero1p was shown to be a cysteine rich and highly glycosylated molecule associated 
with the ER membrane. Studies by Frand and Kaiser (Frand and Kaiser, 1999) showed 
that Ero1p was required for the oxidation of the yeast PDI analogue Pdi1p and that the 
N-terminal active site of Pdi1p formed mixed disulphide bonds with Ero1p in vivo 
showing that Ero1p directly oxidises Pdi1p. Ero1 family members have been shown to 
have a large amount of cysteine residues in their structure which are essential for their  
 
  Introduction 
8 
 
 
 
 
Figure 1. Model for control of the PDI redox state by Cys131 dependant feedback regulation of 
Ero1α a, Under reducing ER conditions, PDI accumulates in the reduced form. Reduced PDI is a 
substrate for oxidation by Ero1a. A thiol–disulphide exchange reaction between Ero1a (in the active 
form) and PDI then results in the formation of oxidized PDI. By this mechanism, the activity of Ero1a 
counterbalances reducing ER conditions. b, Under oxidizing ER conditions, PDI is predominantly 
oxidized and the outer active-site disulphide of Ero1a will, therefore, preferentially react with Cys131. 
The resulting OX2 configuration of Ero1a is inactive because the outer active Cys94 is covalently 
blocked by Cys131.  (Diagram and description adapted from Appenzeller-Herzog et al, 2008). 
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folding and function (Tu et al, 2000). The number of different disulphide bond states 
was later found to be part of a regulatory system of Ero1, with at least one of them 
most likely being a quiescent state for the protein. Benham et al (2000) showed that 
Ero1α exists in two oxidised redox forms in vivo, OX1 and OX2, and the switching 
between the two directly regulates enzymatic activity (Appenzeller-Herzog et al, 
2008).  Also, the activation of Ero1α is directly linked to availability of reduced PDI, 
giving evidence of a feedback loop control of ER redox (see Figure 1). Work by 
Sevier et al (Sevier et al, 2007) has identified two disulphide bonds in Ero1p that must 
be reduced in order for the protein to have catalytic activity. The cysteine pairs located 
at Cys90-Cys349 and Cys150-Cys295 (see Figure 2) affect the activity of the protein 
in a redox dependent manner. When these cysteines are in their reduced form the 
Ero1p is catalytically active and it is not when they are found in the oxidised 
disulphide form. Sevier et al (Servier et al, 2007) suggest that the regulation of the 
activity of Ero1p in this manner aids the cell in governing the flow of oxidising 
equivalents within the ER which allows the cell to maintain the optimum conditions 
for native disulphide formation. The method by which Ero1α in mammalian cells is 
regulated is based on the same principle of disulphide bond formation but the process 
is different. Whereas the yeast protein is activated by the reduction of two cysteine 
pairs, Ero1α is controlled by the formation of regulatory disulphide bonds between 
non-catalytic cysteines and cysteines located within the first active site of the protein 
(Baker et al, 2008). The formation of a disulphide bond between Cys94 and Cys131 
covalently blocks Cys94 which is the first shuttle cysteine and catalytically essential to 
the Ero1α function (Appenzeller-Herzog et al, 2008).  
The identification of these regulatory bonds in both yeast Ero1p and mammalian 
Ero1α showed that whilst both used the formation of these disulphide bonds as a  
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Figure 2. Comparison of the regulatory cysteine residues for Ero1p and Ero1α. a, 
Structure of Ero1p showing the locations of regulatory cysteine residues. Cystein side 
chains are depicted by green and yellow spheres. b, Schematic representations of the 
locations of the cysteine residue connectivity in Ero1p and Ero1α. The cysteines are 
shown as yellow, green (outer active site) or blue (inner active site) circles with 
amino-acid numbering, and disulphides as thick grey (likely structural), black (active 
site) or red (reported or inferred regulatory function) lines.   (2a was adapted from 
Gross et al, 2004 and 2b was adapted from Appenzeller-Herzog et al, 2008) 
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control mechanism, the relative positions of the bonds and the method of activation 
were different. This difference is as yet unaccounted for and it is unknown why this 
change has occurred or what its implications are to the functions of the otherwise 
similar molecules.  
Two individual Ero1 proteins have been found in mammals and humans, Ero1α and 
Ero1β, both of which are able to rescue S.cerevisiae from several phenotypic changes 
seen by the loss of Ero1p activity (Cabibbo et al, 2000). The CKY559 is a 
thermosensitive Ero1-1 yeast mutant strain. The cells are unable to grow at 37°C, 
show inefficient ER-Golgi transport of disulphide rich proteins and have an increased 
sensitivity to DTT. A series of experiments showed that transformation with the 
human version of Ero1α was able to rescue the yeast from each of these defects with 
the transformed cells able to grow viably at 37°C, having a reduced sensitivity to DTT 
and increased transport of a reporter protein CPY along the ER-Golgi pathway.  
 Ero1α is up regulated by hypoxia (Gess et al, 2003) and ER stress (Marciniak et al, 
2004) whilst Ero1β expression is induced via the UPR (Pagani et al, 2000). Some 
tissue specificity has also been noted between the two sub families, with Ero1α being 
more universally expressed whilst Ero1β is more tissue specific, being highly 
expressed in the pancreas, stomach and testes (Dias-Gunasekara et al, 2005). 
Benham et al (2000) looked into the complexes formed between Ero1 and PDI using 
pulse chase experiments to determine if Ero1-PDI complexes were the intermediates in 
the oxidation of PDI or if Ero1 was acting as a folding substrate for PDI instead.  As 
the group was only able to see the complexes one hour after the start of the experiment 
it was determined that the complexes were intermediates in PDI oxidation. Work by 
Tu et al (Tu et al, 2000) followed up on the previous observations by Anfinsen et al 
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(Anfinsen et al, 1963) into the role of FAD in the pathway. It was found that Ero1p 
was a FAD-binding molecule and that they could reconstitute an oxidative folding 
pathway using RNaseA as a substrate, using only Ero1p, PDI and FAD. Next, 
mutagenesis assays on the structure of both Ero1α and Ero1p (Bertoli et al, 2004) 
showed that there is a complex system of inter- and intra-molecular disulphide bond 
transfers between FAD and PDI. Using a panel of cysteine replacement Ero1 mutants 
to assess the underlying molecular mechanisms of the proteins action the group 
showed that two cysteine triads, Cys85-Cys94-Cys99 and Cys391-Cys394-Cys397, 
aid in electron transfer, with PDI forming mixed disulphides with Cys94 of Ero1. 
Deletion of these triads resulted in reduced disulphide bond formation and ability to 
rescue Ero1 knock out mutant yeast.    
As for the final electron acceptor in the chain, it is believed that Ero1 family members 
will pass their electrons onto molecular oxygen in vivo although this has only been 
demonstrated by in vitro experiments. The electrochemistry of Ero1 suggests that 
oxygen will indeed be at least one of the electron acceptors in vivo, but this will lead to 
the unwanted generation of reactive oxygen species (ROS) by the bond formation. 
Each disulphide bond formed by Ero1 in this way would generate one molecule of 
hydrogen peroxide (Hoober et al, 1996). This generation of ROS species, as well as 
the need of the redox potential of the ER to be most favourable for disulphide bond 
formation, suggests that there must be tight regulation of Ero1 proteins, an observation 
corroborated by the presence of regulatory disulphide bonds in the Ero structure. 
However recent work by the likes of Tavender and Bulleid (Tavender and Bulleid, 
2010) has shown the presence of ER peroxidases which help protect cells from such 
oxidative stress from disulphide formation. Peroxiredoxin IV (PrxIV) was shown to  
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Figure 3. Summary of oxidative protein folding. PDI accepts electrons from protein-
folding substrates, thereby oxidizing the thiol (SH) groups in the protein’s cysteine 
residues and resulting in the formation of disulphide bonds. Ero1 uses an FAD-
dependent reaction to transfer electrons from PDI to molecular oxygen, resulting in the 
production of ROS in the form of hydrogen peroxide (H2O2). Reduced glutathione 
(GSH) can assist in disulphide-bond reduction, which occurs when there is a overload 
of proteins to fold or an accumulation of misfolded proteins, and results in the 
production of oxidized glutathione (GSSG). (Diagram and description adapted from 
Zhang and Kaufman, 2009) 
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metabolise the hydrogen peroxide produced by Ero1 and PrxIV was preferentially 
hyperoxidised over other peroxiredoxins due to the increased levels of H2O2 from 
Ero1 disuphide bond formation.   
Overall the PDI and Ero1 families work together to produce the main source of 
disulphide bonds in eukaryotic cells. Ero1 couples with FAD to use the oxidising 
power of oxygen to generate disulphide bonds which are then passed over to PDI, 
which in turn transfers them over to folding secretory proteins, all via a series of thiol-
disulphide exchanges (see Figure 3). 
As mentioned previously, experiments with human Ero1α and Ero1β have shown that 
the proteins are able to rescue the lethal effects of Ero1p knock out in yeast (Cabibbo 
et al, 2000). This suggests that the function of the Ero family is most likely 
evolutionarily conserved from yeast in multicellular organisms. However there are 
some indications that Ero proteins in mammals are required for specific proteins in 
vivo in different physiological contexts. 
A 2008 paper by Tien et al (Tien et al, 2008) has suggested a novel function for Ero1 
in Drosophila melanogaster which raises some interesting new ideas with regard to 
Ero1 function. In their study, using a mosaic screen in Drosophila flies, isolated 
mutations in Ero1L were found to cause Notch-related phenotypes. Using the eyeless-
flipase system the group produced mutants of the 3L chromosome, which displayed a 
bristle-tufting phenotype of the head and thorax epidermis in homologous mutants. 
Also seen in this mutant group was notching of the wing margin and thickening of 
wing veins. These phenotypes are indicative of a problem with lateral inhibition in the 
flies, which is normally then linked back to an issue with the Notch signalling 
pathway. Genetic analysis and loss of function rescue experiments then confirmed that 
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the mutations were in the Drosophila Ero1L gene and that the loss of Ero1L was 
causing a build up of misfolded Notch receptor proteins in the ER causing induction of 
the UPR. 
The Notch signalling pathway is an evolutionarily conserved pathway used by 
metazoans in a large variety of developmental processes across different organisms 
(Tien et al, 2008) as a means of controlling cell fates via short range cell-cell 
interactions. Notch is highly conserved between organisms, with Notch like proteins 
being characterised in many organisms including Caenorhabditis elegans, sea urchins 
and many vertebrate species, including humans (Artavanis-Tsakonas et al, 1999). In 
order for proper development to take place, multicellular organisms need to spatially 
and temporally regulate and coordinate cell behaviour and growth.  Notch signalling is 
one way in which organisms are able to do this. 
Moohr first noted a phenotype related to the Notch receptor in 1919 (Moohr, 1919) 
during studies into Drosophila melenogaster. He noted that a partial loss of function 
resulted in notches forming along the wing margins. Later studies by Poulson 
(Poulson, 1940) showed that lethal loss of function mutations caused tissue that was 
originally destined to become epidermis was instead forming neural tissue.  
Interaction studies, both molecular and genetic, showed several other proteins which 
interacted with Notch to either regulate or transmit the Notch signal. Studies in 
Drosophila showed two partially redundant Notch ligands, Delta and Serrate. 
Mammalian studies showed similar results with Delta-like (Dll) and Jagged, a Serrate 
homologue (Li et al, 1997). Downstream of Notch activation was shown to be the 
transcription factor Suppressor of Hairless, Su(H), or in mammals RBP-Jk, activation. 
These proteins are the main downstream effectors of the Notch pathway and activate 
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expression of the Notch pathways primary targets, the genes of the Enhancer of split 
locus. These genes express nuclear basic helix-loop-helix proteins and these factors in 
turn affect the regulation of other genes such as the Achaete-Scute complex, which 
contains proneural genes which express proteins that are involved in the isolation of 
epidermal and neuronal cell fates (Bailey and Posakony, 1995). 
 Over the years further studies have elaborated on this initial work to give our current 
more detailed understanding of the Notch pathway and its constituent parts as seen in 
Figure 4. 
Notch signalling is a short range cell to cell signalling pathway. The short range of the 
pathway is due to the transmembrane proteins that make up its components. Both the 
Notch receptor and ligands are cell surface type I transmembrane proteins 
(Schweisguth, 2004). Vertebrates have four different Notch receptors, Notch 1, 2, 3 
and 4 and two ligand families, Delta-like and Serrate/Jagged. Notch 1 is seen in most 
fetal tissues and is abundant in the spleen, lungs and brain stem and is in most adult 
tissues, primarily in lymphoid tissue. Notch 2 is universally expressed in the embryo 
and is found in the brain, heart, kidney, lung, skeletal muscle and liver of adults 
(Simpson et al 2011). Notch3 is ubiquitously expressed in the both the embryo and 
adult vertebrates. Notch 4 has not been seen widely in adult tissue but is highly 
expressed in the fetal heart, moderately in the lung and placenta and at low levels in 
the liver, skeletal muscle, kidney, pancreas, spleen, lymph node, thymus, bone marrow 
and fetal liver.  
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Figure 4. Schematic diagram of Notch structure and pathway. a, Schematic diagram of Notch structure, 
showing EGF-repeats, LNR and HD domain. Vertebrate Notch undergoes S1 cleavage within the secretory pathway 
to generate the heterodimeric receptor that is found on the cell surface. b, Notch is activated by binding to ligands 
of the Delta/Serrate/Lag-2(DSL) family. Activated Notch undergoes sequential cleavages, first by an ADAM 
family metalloproteinase at the S2 site, then at the S3 and S4 sites by a γ-secretase. These cleavages release the 
Notch intracellular domain (NICD), which translocates to the nucleus where it interacts with members of the CSL 
family of transcription factors, and recruits co-activators to activate transcription of Notch target genes. (Diagram 
and description adapted from Pratt et al, 2011) 
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Serrate/Jagged is universally expressed in humans whilst Delta-like is expressed 
mainly in the heart and pancreas, with lower expression levels in the brain and 
muscles. The Serrate/Jagged family differs from the Delta-like family due to the 
presence of a cysteine-rich domain which is lacking in Delta-like. 
After its synthesis and processing Notch is presented at the plasma membrane as a 
heterodimer, made up of its membrane tethered intracellular domain, known as the 
NTM, and the ectodomain called the Notch extracellular domain (NECD). The two 
domains have been shown to interact in a non-covalent Ca
2+
 dependant manner (Rand 
et al, 2000). 
After a ligand binds to the Notch receptor, Notch is then subject to two separate 
proteolytic cleavages. Ligand binding makes the S2 domain of the NTM sensitive to 
cleavage (Brou et al, 2000). The primary cleavage is mediated by an ADAM family 
metalloproteinase, such as ADAM10 or 17 (Watt et al, 2005). This S2 cleavage causes 
the formation of a membrane bound active form of the receptor known as the Notch 
extracellular truncation (NEXT) and the release of the ectodomain.  NEXT is then 
subject to two cleavage events at the S3 and S4 sites, catalysed by a γ-secretase 
complex, Presenilin-Nicastrin-Aph1-Pen2 protein complex (Fortini, 2001). These 
cleavages cause the release from the plasma membrane of the Notch intracellular 
domain (NICD) into the cell and the expulsion of a small peptide Nβ to the exterior of 
the cell. The NICD is the active form of the Notch receptor and the function of Nβ, if 
any, is currently unknown. 
The NIDC then passes into the nucleus where it complexes with a member of the 
RBP-Jk (also known as the CSL) family of DNA binding proteins. The complex then 
recruits a Mastermind-like (MAML) transcriptional co-activator protein and the 
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transcription of the target genes, such as the Hes and Hey family, begins. In the 
absence of Notch, RBP-Jk recruits repressor complexes which bind the cis-regulatory 
region of the target genes (Schweisguth, 2004). Thus Notch activation is a switch from 
gene repression to activation. Of note is that the NICD has not been detected in the 
nuclei of signal receiving cells, leading some to suggest that the NICD works at very 
low concentrations below that detectable by normal immune-detection techniques 
(Schroeter et al 1998). 
The Notch1 gene encodes for a 300kD single pass transmembrane receptor. The 
extracellular domain of Notch includes 36 tandem EGF-like repeats and three cysteine 
rich LIN-12/Notch repeats (LNRs) known as the negative regulatory region (NNR), as 
well as a heterodimerisation domain (HD). The NNR acts to prevent ligand 
independent activation of Notch, seen in knock out experiments of this domain which 
result in a constitutively active form of Notch (Weng et al, 2004). Conversely the 
intracellular domain includes six tandem ankyrin repeats, a PEST sequence and a 
glutamine rich domain (Artavanis-Tsakonas et al, 1999).   
Genetic mosaic studies (Heitzler and Simpson, 1991) have shown Delta and Serrate to 
be short range and non-autonomous, which correlates with the ligands being 
transmembrane proteins can only affect adjacent cells. EGF repeats of Notch and the 
conserved extracellular DSL region of the ligands mediate the interaction between 
Notch and its ligands.  Figure 5 shows a schematic representations and comparisons of 
the full structures of Notch and DSL ligands from humans, Drosophila and C. elegans. 
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Figure 5. Schematic diagrams of the structure and domain organizations of Notch 
receptors (a) and DSL ligands (b) in Homo sapiens, Drosophila melanogaster and 
Caenorhabditis elegans. (Diagram taken from Gordon et al, 2008) 
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The Notch pathway is an example of signalling that involves regulated intramembrane 
proteolysis (RIP) (Brown et al, 2000). This has several implications on how Notch 
functions and thus how it is able to be regulated by the cell. As the cleavage of Notch 
is an irreversible event, coupled with the fact that the cleavage releases the ligand 
which has bound to Notch, each molecule is able to act only once. This means that the 
regulation of the signal can’t be dependent on receptor desensitization (Schweisguth, 
2004). Also the signaling is direct, with no involvement of any secondary molecules. 
These factors limit any potential to amplify the signal.  
Evidence from Drosophila has shown that normal development is highly dependent on 
Notch and Delta gene dosage. This would seem to suggest that the amount of either 
the receptor or ligand is an important and highly regulated factor in development. The 
timing and activation of Notch is clearly dependant on the presence of both the 
receptor and ligand. However the pattern of Notch activation does not coincide with 
the extensive expression of its ligands, suggesting that there must be regulatory 
mechanisms which restrict Notch activation. 
One such mechanism for regulation involves the Dll ligand. Work on Drosophila lead 
to the study of the neutralised (neur) gene, which was shown by (Lai et al, 2001) to 
cause Notch-like mutant phenotypes. This gene was found to act in the regulation of 
the ubiquitylation of Dll and that when tagged with ubiquitin, Dll is marked for 
endocytosis by the cell. Clonal analysis showed that neur acted to upregulate the 
signalling activity of Dll, after which (Parks et al, 2000) hypothesised that the 
endocytosis of Dll in the signal sending cell in some way helps promote Notch 
activation in the receiving cell. 
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Endocytosis is involved in many signalling pathways and has also been hypothesised 
to be involved with Notch, as mentioned above. In addition to this example, other 
studies have shown other functions of endocytosis in Notch signalling. Parks et al 
(Parks et al, 2000) suggested that  endocytosis of a ligand bound to Notch may be 
needed to provide a pulling force that leads to the exposure of the S2 domain, either by 
a conformational change or by dislocating the Notch heterodimer. Other potential 
functions of endocytosis in the pathway may be to allow γ-secretase activity, which is 
mostly seen in an intracellular compartment (Gupta-Rossi et al, 2004), or that receptor 
endocytosis and lysosomal targeting may be needed in order to help prevent any ligand 
independent activation of the pathway (Childress et al, 2005). 
Another example of Notch regulation is the addition of carbohydrate chains to Notch, 
which can alter the ability of the ligands to activate the receptor. This addition takes 
place in the Golgi by O-fucosytransferase 1 (Ofut1), potentially an important point to 
consider when looking at Notch-Ero interactions (Artavanis-Tsakonas et al, 1999). 
Fructose molecules are added to specific Serine and Threonine residues in the Notch 
EGF-like repeats (Schweisguth, 2004) and loss of Ofut1 function mimics loss of Notch 
function in Drosophila and mice (Shi and Stanley, 2003). Transfection studies have 
shown that when Ofut1 acts on Notch, interaction between the ligands and receptors is 
increased; however its overexpression leads to loss of correct lateral inhibition in 
development in Drosophila and several phenotypical mutations also seen in lack of 
Notch function. Okajima and Irvine (Okajima and Irvine, 2002) has suggested that 
since the activity of Ofut1 is controlled developmentally and it’s over expression stops 
receptor-ligand binding, that one of its many apparent functions may be one method of 
Notch regulation. These opposing influences of Ofut1 on notch signalling could 
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involve positive and negative roles for distinct EGF domains on Notch and their 
differing affinities for Ofut1 
Fringe, a glycosaminyl transferase involved in boundary formation in Drosophila and 
mammals, also interacts with Notch and modifies O-linked fructose on specific EGF-
like repeats. One such repeat is EGF12 which has been shown to act in ligand binding. 
Binding assays in cultured cells by Lei et al (Lei et al, 2003) have shown that Notch 
modified by Fringe has a greater binding affinity for Delta and a reduced affinity for 
Serrate. Together with other studies in this area, it has been suggested that the Notch 
ligands have lectin-like properties, as they are able to bind to Notch with differing 
affinities depending on the type and extent of sugar modifications of Notch.  
Evidence of a feedback loop of regulation in Notch signalling was first seen in genetic 
mosaic experiments in Drosophila and later direct evidence came from the studies of 
Heitzler and Simpson (Heitzler and Simpson, 1991) with C.elegans. Dynamic changes 
in the expression of LIN-12 and LAG-2 (homologues of Notch and Jagged) in 
developing cells in the worms were observed to be consistent with those seen in other 
transcriptional feedback loops in other biological systems. This feedback loop 
provides a mechanism by which Notch signalling can amplify small initial differences 
between cells in order to consolidate those differences. Thus intrinsic or extrinsic 
factors can bias developing cells so that the critical level of Notch signalling can be 
obtained to alter the cells developmental path (Seugnet et al, 1997). 
Posttranscriptional proteolytic cleavage events help to regulate Notch activity. Notch 
is cleaved at the S1 site in the trans-Golgi network by a furin-like convertase before its 
presentation to the cell surface as a heterodimer (see Figure 4a). This generates the 
extracellular and transmembrane subunits of Notch, held together by the HD domain. 
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This processing is required for active signalling in mammals but seems to be a 
dispensable process in Drosophila (Kidd and Leiber, 2002). 
Notch is used widely developmentally, resulting in different outputs by the cell 
depending on the situation in which it finds itself. Thus different NICD- RBP-Jk targets 
are expressed in different cells by the same ligand activation (Cooper et al, 2000). 
Therefore the selective genome response to Notch signalling must also be highly 
regulated. This area is still being investigated with the nature and co-factors of the 
NICD- RBP-Jk complex the most likely area of control, but chromatin structure and 
NICD competition with repressor complexes have also been suggested as possible 
regulatory mechanisms (Schweisguth, 2004). 
Over time extensive loss and gain of function mutation studies using Notch have been 
carried out across the animal kingdoms, with studies into Drosophila, fish, birds, mice 
and humans to name but a few. These studies have all shown a remarkable 
conservation of function for the Notch pathway, with mutations leading to disruption 
of somite formation, lymphoid development, angiogenesis and many neural defects in 
vertebrates (Egan et al, 1998). In Drosophila where data is most abundant it seems that 
practically all tissues, across all three germ layers, are affected by Notch. 
The Notch pathway has been shown phenotypically in both vertebrates and non-
vertebrates to have a deep-seated role in controlling cell fate choices between adjacent 
cells regardless of their primary developmental similarity (Artavanis-Tsakonas et al, 
1999). Notch signalling is therefore vital to lateral inhibition events, which lead to 
segregation of groups of cells, definitions of borders between areas and causing 
lineage differentiation from within groups of cells.  Data from Heitzler and Simpson 
(Heitzler and Simpson, 1991) has shown, by placing cells expressing differing levels 
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of either Notch or one of its ligands next to one another that only a small difference in 
the amounts of one ligand ratio between cells can cause one cell to take on a lateral 
inhibition signalling role. Then as development proceeds, these initial differences, 
caused by random events or any number of factors, are stabilised or augmented by 
Notch signalling leading to the dictation of a cells final fate. Examples of Notch in 
lateral inhibition processes are evident in several areas of Drosophila development 
such as in the developing eye disk (Fanto and Mlodzik (1999). Adjacent photoreceptor 
precursor cells R3 and R4 experience a Wingless signal gradient emanating from the 
imaginal disk, which upregulates the expression of Delta. R3 which is closer to the 
source of this signal expresses higher levels of Delta giving rise to R3 fate. At the 
same time this activates Notch in the adjacent R4 precursor cell, pushing it into its R4 
fate. This is a prime example of the non-autonomous effects of Notch, and how it can 
act to push cells into differing cell fates over a range of only two cells. 
However, it must be noted that for Notch to be able to influence so many 
developmental processes it must also interact with many other factors and also must be 
highly dependent on the developmental context in which it is found. Whilst the 
activation of Notch can be seen in many cells to lock them into a certain 
developmental fate, preventing other paths being taken, cells are not terminally locked 
into this fate by Notch and can react to other factors.  Ahmad et al (Ahmad et al, 1995) 
note that Notch acts in terminally differentiated cells such as post-mitotic neurones, 
and suggests that Notch may confer on them some level of developmental plasticity. 
Related to the Notch pathways role in lateral inhibition and other such developmental 
processes is the function of the Notch ligands in cell adhesion. Lindner et al (Lindner 
et al, 2001) have shown that secreted forms of the Jagged1 extracellular domain 
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reduce adhesion of cells to the extracellular matrix, lose focal adhesion formation, and 
increase the amount of cadherin based intercellular junctions. Conversely, Dll1 
promotes cell adhesiveness. Cell mixing experiments (Lowell and Watt, 2001) have 
shown that keratinocytes expressing a higher level of Dll1 were more cohesive in 
culture, but the effect did require the cytoplasmic domain of Dll1.  
Notch and Jagged have also been studied into widely in regards to their role in skin 
and hair follicle development in mammals, with expression profiles for both well 
mapped out (Watt et al, 2008). These studies have noted that Notch expression differs 
between embryonic and adult epidermis with the expression of the different pathway 
components being highly dynamic as the epidermis develops and is maintained. This 
change in function over time is shown well by Pan et al, who showed by deletion of γ-
secretase that Notch function is not required to initiate the formation of hair follicles in 
the embryo (Pan et al, 2004). However, in postnatal skin the lack of Notch function 
causes the interfollicular regions to hyperproliferate, and the hair follicles to convert 
into cysts which undergo proliferation akin to that seen in the interfollicular epidermis. 
Notch signalling also displays a similarly wide range of functions in cancers and 
tumour formation. Whilst Notch can act as a tumour suppressor in the skin of mice 
(Nicolas et al, 2003), where loss of Notch or its suppression by inhibition of the 
function of MAML1 caused spontaneous squamous cell carcinomas, it can also have 
the opposite effect. In human T cell acute lymphoblastic leukaemia, studies have 
shown that a gain of Notch function is one of the causes of the condition. As well as 
this, mutations in the ADAM metalloprotease Kuzbanian (Kuz), involved in the 
primary cleavage of Notch, have been linked to Alzheimer’s disease development via 
β-amyloid precursor processing (Hardy and Israel, 1999).  
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Tien et al (Tien et al, 2008) produced data indicating that Ero1L in drosophila 
specifically affects Notch signalling during fly development.  Lateral inhibition, 
follicle cell differentiation and inductive signalling were all shown to be defective in 
the Ero1L mutants, phenotypes usually seen when there are problems in Notch 
signalling. However, several other pathways such as decapentaplegic and hedgehog, 
involved in anterior-posterior boundary formation in wing development, were 
unaffected in the mutants. This coupled with the fact that several other membrane 
proteins were expressed and localised normally in the Ero1L mutants showed that 
Ero1L was specifically affecting Notch activity and not that of other similar pathways. 
Finally the cells would normally induce the UPR in the mutants to deal with the excess 
of unfolded Notch that was building up inside the ER lumen. In Ero1L/Notch double 
knock outs, this effect was reduced. Taking all this data into account, the group 
suggested that Notch is either a very sensitive target when Ero1L is disrupted or that 
Notch is in fact a major substrate for Ero1L. 
Analysis of the NECD showed the group that Ero1L was involved in some form in the 
folding of this protein region. This gave two possibilities for the domains that the 
Ero1L was aiding the folding of, either the EGF repeats or the LNR region. In the kiga 
Ero1L mutants, only Notch was seen to exhibit high levels of ER retention and not any 
other EGF containing membrane proteins (Tien et al, 2008). The LNR was then 
investigated to see if its cysteine bridges were affected by the Ero1L loss. LRN are 
found in all known Notch homologues including Lin12 and human Notch 1-4 and are 
only seen on two other unrelated groups of mammalian proteins, which have no 
homologues in Drosophila. The biochemical data generated by the group indicated 
that it was the disulphide bonds in the LNR regions that were affected when Ero1L 
function was lost. This was done by examining the secretion efficiency of LNR and 
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EGF domains tagged with a signal peptide for secretion when they were properly 
folded, in S2 cells. When Ero1 function was reduced through iRNA the EGF secretion 
was unaffected, however a significant decrease was seen in LNR domain levels in the 
cell media, suggesting Ero1 is needed for correct formation of the LNR region. 
Western blot analysis of also confirmed this by showing that when Ero1 was knocked 
down there was an increase in free thiol groups on the LNR regions, shown via an 
increase in AMS binding to the LNR. AMS is able to bind to free thiol groups and 
increase the molecular mass of the protein by 490D per cysteine residue. 
The loss of function phenotypes seen in the drosophila Ero1 mutants were rescued by 
over expression of human Ero1α, and this coupled with the knowledge that human 
Notch has the same unique LNR regions as the Drosophila suggests that the role of 
Ero1 in the Notch pathway might be conserved in mammals.   
My project aims to gather more information on this potential link between Ero1α and 
the Notch pathway proteins in mammalian cells. Specifically, the two main hypotheses 
we shall be investigating are: 
 The oxidative folding of the Notch protein is directly catalysed by the Ero-PDI 
pathway in the ER. 
 Ero1 and the Notch pathway interact with each other causing changes to the 
actions of one or the other pathway, for example via transcriptional modulation 
of the Ero1 protein by Notch signalling. 
As has been shown by the data discussed above these links have been previously 
shown to exist in insect systems and we wish to investigate if these links have been 
conserved in mammalian development. By using a combination of western blotting, 
immunoprecipitation and immunocytochemistry we shall investigate if mammalian 
  Introduction 
29 
 
Ero1 and Notch interact in a manner as has been suggested by previous work or if this 
has been evolutionarily lost in favour of a different system 
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2. Materials and Methods 
2.1 Antibodies 
The polyclonal rabbit anti-serum against PDI was raised against purified rat PDI as 
described (Benham et al., 2000). αEro1 (D5) was raised in rabbit against reduced, 
non-reduced and denatured forms of an E. coli expressed and purified MBP fusion 
protein (Mezghrani et al., 2001). The monoclonal mouse antibody, raised against 
recombinant Ero1α (2G4) was a gift from Prof. Roberto Sitia, Milan. The polyclonal 
goat anti-serum, against hJagged1 (C20) was a gift from Dr. Carrie Ambler and is 
available commercially (Santa Cruz Biotechnology Inc.). The polyclonal mouse anti-
serum, against the V5 (antigen GKPIPNPLLGLDST, Sigma), the monoclonal anti-
Myc antibody clone 9B11 and the polyclonal antibody anti-Myc (antigen 
EQKLISEEDL, both Cell Signalling) were commercially available. 
 
2.2  Molecular Biology 
2.2.1 cDNA constructs 
The Ero1α-wt cDNA was a gift from Prof. Roberto Sitia, Milan. The Ero1α mutants, 
C394A and C397A were made by Dr. Adam Benham by site directed mutagenesis 
using the Stratagene Quikchange kit according to the manufactures instructions 
(Benham et al., 2000). The hJagged1, hNotch1, NICD-FL and NICD-ER neo cDNAs 
were gifts from Dr. Carrie Ambler, Durham. The Ero1β-HA was a gift from Prof. 
Roberto Sitia, Milan. 
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2.2.2 Escherichia coli transformation 
Plasmid cDNA was used to transform DH5α and XL10-Blue supercompetent cells (a 
gift from Max Brown, commercially available). One μl plasmid DNA was mixed with 
50 μl bacteria cells and incubated on ice for 30 min. Bacteria were heat shocked at 
42
o
C for 20 sec, incubated on ice for a further 2 min prior to mixing with 950 μl of 
pre-heated (42
o
C) LB-broth (Tryptone 10g/l, yeast extract 5g/l, NaCl 5g/l) 
supplemented with 0.1mg/ml ampicillin at 37
o
C for 1 hr with constant agitation. 
Bacteria were centrifuged at 6,200 rpm for 2 min at room temperature and the 
resuspended bacterial pellets were spread on LB-agar plates (10 g/l tryptone, 5 g/l 
yeast extract, 10 g/l NaCl, 15 g/l agar) supplemented with 0.1 mg/ml ampicillin and 
grown overnight at 37
o
C with constant agitation. The following day a single colony 
was inoculated in 5 ml of LB-broth supplemented with ampicillin (0.1 mg/ml), and 
grown overnight at 37
o
C with constant agitation. The overnight culture was used to 
extract plasmid DNA (using the Qiagen MiniPrep according to the manufacturers’ 
protocol)    
2.2.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to analyse DNA restriction digest products. The 
appropriate amount of agarose (Bioline) to make a 1% solution was disolved in a 
suitable volume of TAE (20 mM Tris, 0.002% glacial acetic acid, 0.5 mM EDTA, pH 
8.0) buffer by heating in a microwave. Ethidium bromide was added to a final 
concentration of 0.6 μg/ml prior to pouring into a tray to set. The gel was submerged 
in TAE buffer and DNA samples were loaded into the wells after mixing 6:1 with 6x 
loading buffer (15% Ficoll; type 400, (Pharmacia), 5 mM EDTA, pH 8.0, 0.25% 
  Materials and Methods 
32 
 
bromophenol blue). Following electrophoresis, gels were visualised by UV 
illumination and photographed using a BioRad Gel Doc.  
2.3 Cell Culture 
Human cervical carcinoma HeLa cells were maintained in minimum essential medium 
(MEM, Invitrogen) and human embryonic kidney carcinoma HEK293 cells were 
maintained in Dulbecco’s modified Eagles’s medium (DMEM, Invitrogen), both 
supplemented with 8% fetal bovine serum (FBS, Sigma), 2 mM glutamax (Invitrogen), 
100 units/ml penicillin and 100 μg/ml streptomycin (Invitrogen) at 5% CO2. Both cell 
lines were serially passaged at 70-80% confluency using 0.05% trypsin (Trypsin-
EDTA, Invitrogen) every three to four days. 
2.4 Cell transfection 
2.4.1 Lipofectamine transfection 
Transfections with Lipofectamine 2000 (Invitrogen) were performed according to 
manufacturer’s instructions. Sub-confluent cells in 4cm dishes were washed either 
singly (HEK293) or twice (HeLa) with PBS (Invitrogen), and transfected with 1 g 
DNA and 3μl Lipofectamine for 5 hours in Optimem serum free medium (Invitrogen). 
The medium was replaced after 5 hours with the relevant complete medium for the cell 
line and the cells analysed 24 hours post-transfection. 
2.4.2 Roche X-tremeGENE transfection 
Transfections with X-tremeGENE (Roche) were performed according to 
manufacturer’s instructions. Sub-confluent cells in 4cm dishes were washed either 
singly (HEK293) or twice (HeLa) with PBS (Invitrogen), and the relevant complete 
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medium for the cell line was replaced. The cells were then transfected with 1 μg of 
DNA in 3μl of reagent and the cells analysed 24 hours post-transfection. 
2.5 Cell lysis 
Lysates were prepared from cell lines 24 hours after transfection. Cells were washed 
either singly (HEK293) or twice (HeLa) with PBS (Invitrogen) and placed onto an ice 
cold metal tray. 400 μl of lysis buffer (20 mM MES, 30 mM Tris-HC, 100 mM NaCl, 
1% TX100, 1µg/ml CLAP, pH 7.1), supplemented with 20 mM N-ethylmaleimide 
(NEM) where required, was added to each dish and the cells removed from the dish 
with a plastic scraper. The lysate was transferred to a 1ml eppendorf tube and 
centrifuged for 10 minutes at 14,200g to remove the nuclei. The resulting lysates were 
either used immediately or flash frozen in liquid nitrogen and stored at -20°C for later 
use.  
2.6 Immunoprecipitation 
Immunoprecipiations (IP) were carried out using the required lysate and 1 l of 
monoclonal antibodies or 8 μl of polyclonal antibodies immobilised on 50 l of a 20 % 
suspension of Protein A or G sepharose beads (Sigma) for 2 hours at 4
o
C. Beads were 
spun down at 4000g for 30 seconds and the lysis buffer was replaced. Beads were 
agitated and then washed again in the same manner. Fifty or one hundred μl of the 
relevant beads were added to 100μl of lysate and rotated together for 1 hour at 4°C. 
The beads were then washed three times as described previously. The resulting beads 
were prepared for SDS-PAGE and Western blotting as described below. 
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2.7 SDS-PAGE 
Cell lysates or immunoprecipitates were mixed 1:1 with sample buffer ((Laemmli, 
1970) comprising 0.125M Tris HCl, 2% SDS, 10% glycerol, 0.01% bromophemol 
blue, pH 6.8) and supplemented with 50mM dithiothreitol (DTT), heated for 5 minutes 
at 95°C and then analysed by SDS-PAGE (resolving gel consists 10% acrylamide, 
0.375 M Tris (pH 8.8) and 0.1% SDS, 0.1% APS, 0.04% TEMED; stacking gel 
consists of 5% acrylamide, 0.125M Tris (pH 6.8), 0.1% SDS, 0.075% APS and 
0.075% TEMED). Samples were loaded and run at 50mA for 30 minutes using a Bio-
rad power pack 200. 
 
2.8 Western Blotting 
Following SDS-PAGE proteins were transferred to PVDF membranes (Millipore), 
(primed in methanol), in transfer buffer (190 mM glycine, 25mM Tris in 20% 
Methanol) at 150mA for 2 hrs or 30V overnight using a Bio-rad powerpack 200. The 
membranes were then blocked in 8% milk/TBST (TBST- 150mM NaCl, 10mM Tris 
base (Sigma), pH 8.0 plus 0.8% Tween) for 1 hr or overnight. The primary antibody 
was used at its required concentration (see individual experiements for concentration 
used) for immunoblotting for 1 hour on a roller. Membranes were then washed 4 times 
with TBST, each wash lasting five minutes. Membranes were then incubated with 
corresponding secondary antibodies (DAKO) at 1:3000 for 1 hour and again washed 4 
times with TBST, each wash lasting five minutes. Membranes were visualised by 
ECL+ (GE Healthcare) and exposure to film (Kodak). 
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2.9 Immunofluorescence  
HEK293 cells were grown on 16mm coverslips treated with a 1:10 poly-1-lysine 
solution to aid cell binding. When the cells were 70-80% confluent they were 
transfected with the appropriate cDNA construct (See section 2.4). Coverslips were 
washed 3 times in PBS++ (PBS (Invitrogen), 1.0mM CaCl2 and 0.5mM MgCl2) the 
fixed in 4% paraformaldehyde (in PBS++) for 10 minutes. Coverslips were then 
placed in 50mM NH4Cl for 15 minutes to quench free aldehyde groups before washing 
three time in PBS++. Where needed cells were then permeabilised by placing in 0.1% 
TX100 (in PBS++) solution for ten minutes at room temperature. Coverslips were 
washed three times in PBS ++ with 0.2% BSA (Sigma).  Primary antibodies (αPDI, 
1:500 or αMyc, 1:1000 or αV5, 1:200) were applied in the presence of 0.2% BSA for 
one hour at room temperature before washing three times in PBS++ for five minutes. 
Secondary fluorescent antibodies (ALEXA, Invitrogen) or rhodamine labelled swine 
anti-rabbit Ig (TRITC) were incubated on the coverslips at 1:1000 concentrations for 
one hour. Next coverslips were washed twice in PBS++ supplemented with 0.2% BSA 
(Sigma) then five times in PBS++. Cell nuclei were stained with 1:1000 DAPI and 
washed a final time in PBS++. Mounting of the coverslips onto microscope slides was 
done using vectashield (VECTOR) and analysis was under a Zeiss UV inverted 
microscope system. 
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3. Results 
3.1.  Characterisation of plasmids 
3.1.1. Establishing cDNA stocks for cell transfection 
In order to study the interactions between Ero1α and the Notch pathway proteins we 
needed to generate stocks of cDNA plasmids containing the genes required to cause 
ectopic protein expression in mammalian cell lines. The constructs made available are 
noted in Table 1. 
 
Table 1 – Plasmid constructs used in this project 
Construct Tag Plasmid Restriction Enzyme 
used  
Human Jagged 1 -- pcDNA 3.1 Xho1/BamH1 
Full Length Jagged 1 V5 pcDNA 3.1 Xho1/BamH1 
Human Notch 1 -- pcDNA 3.1 Xho1 
NICD-Full length (Inducible) -- pcDNA 3.1 Xho1 
NICD-Full length (Non-inducible) Myc pcDNA 3.1 Xho1 
Ero1-α (Wild Type) -- pcDNA 3.1 Xho1 
Ero1-α C394A Myc pcDNA 3.1 Xho1 
Ero1-α C397A Myc pcDNA 3.1 Xho1 
 
The plasmids were used to transform XL10-Blue supercompetent cells as described in 
2.2.2. After using the Qiagen MiniPrep kit according to manufacturer protocols to 
extract the cDNA from the E. coli, the concentration of the cDNA collected was 
measured using a nanodrop protocol. An example of the results obtained are shown in 
Table 2;  λ230 is the absorbance measured at a wavelength of 230nm, A260 is the 
absorbance of the sample at 260nm, A280 is the absorbance of the sample at 280nm, 
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260/280 is the ratio of the sample absorbance at 260nm and 280nm, used to assess the 
purity of the sample with a value of around 1.8 generally accepted as ‘pure’ DNA, 
260/230 is the ratio of sample absorbance at 260nm and 230nm used as a secondary 
measure of purity with values in the range of 1.8-2.2 accepted as pure, ng/μl  is the 
sample concentration in ng/µl based on the absorbance at 260nm electronically 
calculated using Beer’s Law). Yields in the range of hundreds of ng/μl are common for 
MiniPrep procedures. 
 
Table 2 – Absorbance measurements of plasmid constructs. 
Construct λ 230 A260 A280 A260/280 A280/ λ230 ng/μl 
Human Jagged 1 7.049 15.893 8.339 1.91 2.25 794.7 
Full Length Jagged 1 6.507 13.825 7.564 1.83 2.12 691.3 
Human Notch 1 5.430 11.467 6.116 1.87 2.11 573.3 
NICD-Full length (Inducible) 18.423 41.071 21.721 1.89 2.23 2053.5 
NICD-Full length (N-I) 9.660 21.717 11.304 1.92 2.25 1085.8 
Ero1-α (Wild Type) 13.726 30.814 16.145 1.91 2.25 1540.7 
Ero1-α C394A 18.654 41.487 21.962 1.89 2.22 2074.4 
Ero1-α C397A 13.418 30.048 15.597 1.93 2.24 1502.4 
 
The three Ero1 constructs have been previously used and characterised by the group. 
The Ero1-α mutants C394A and C397A cannot form the CxxC active site, do not 
compliment Ero1α and act as strong dominant negatives. Since these mutants are 
catalytically inactive, it is of interest to determine whether or not they will 
functionally/physically interact with Notch compared with wild type Ero1a. 
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The cDNA for hNotch1, hJag1, FLJag1, NICD-FLi and NICD-FLni were gifts from 
Dr. Carrie Ambler and not before used by the group. As such samples of these 
constructs were linearised by restriction digest using the enzyme listed in Table 1. 5μl 
of each construct was digested with 1μl of the relevant restriction enzyme,) and 13μl 
of deionised H2O and placed in a water bath at 37°C for one hour. Samples were then 
prepared as described in Section 2.2.3 and run on a 1% agrose gel in order to check the 
molecular mass of the constructs,  to confirm identity and to check for contamination 
of the samples. 
Constructs 1-5 all ran between approximately 10kb and 13kb as expected (personal 
communication, Dr. Carrie Ambler). As seen in Figure 1 all constructs were found to 
have the correct approximate molecular mass. No contamination or artefacts were 
found to be present in any of the samples. 
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Figure 1. Restriction digest of plasmid constructs. Plasmid constructs, Human Jagged 
1 (lane 1), human Notch 1 (lane 2), full length Jagged 1 (lane 3), full length NICD 
inducible (lane 4), full length NICD non-inducible (lane 5), Ero1α wild type (lane 6), 
Ero1α C394A mutant (lane 7) and Ero1α C397A mutant (lane 8) were linearised for 1h 
using relevant restriction enzyme (see Table 1) and run on a 1% agrose gel.   
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3.1.2. Characterisation of Ero1α antibody 2G4 
Antibodies are serum immunoglobulins able to bind to specific antigens with high 
affinity. Due to this property they are often used in biology as useful tools in Western 
blots and immunoprecipitation to identify and isolate proteins, and in 
immunofluorescence for localisation studies. When trying to identify and stain 
proteins from cell lysates the specificity of antibodies is vital to ensure that the correct 
protein is detected and analysed. 
The 2G4 antibody is a monoclonal mouse antibody raised against recombinant Ero1α. 
An analysis of the batch used was needed to confirm its binding specificity and to 
confirm that it identified Ero1α in cell lysates from different cell types.   
To investigate 2G4, HeLa lysates were separated by SDS-PAGE and transferred onto a 
PVDF membrane for Western blotting as described in Chapter 2. Two lanes were then 
immunoblotted with 2G4 and the other two lanes with αPDI (see Figure 1A). The 
control lanes 3 and 4 showed PDI staining as a control for correct protein loading. The 
PDI antibody detects a doublet. Previous unpublished data from our group has found 
that the lower band is PDI and the top band is albumin which has cross reacted with 
the αPDI antibody. This doublet usually occurs in lysate samples in cell washing has 
not removed all the albumin from the cell preparation (Personal communication with 
Dr. Adam Benham). 
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Figure 1. 2G4 binds to Ero1α at varying concentrations. A, HeLa lysates were 
subjected to Western blotting after SDS-PAGE using 2G4 at 1:2 concentration (lanes 1 
and 2) and αPDI at 1:1000 (lanes 3 and 4). A doublet is seen in lanes 3 and 4, with the 
lower band (P) indicating PDI and the higher band (A) albumin which has cross 
reacted with the αPDI. B, the same HeLa lysates were separated by SDS-PAGE and 
immunoblotted with varying concentrations of 2G4; Lanes 1 and 2 at 1:2, lanes 3 and 
4 at 1:5, lanes 5 and 6 at 1:10, lanes 7 and 8 at 1:50 and lanes 9 and 10 at 1:100. 
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The 2G4 staining was very strong in lanes 1 and 2, with a distinct band seen in each 
and with no background staining. The molecular mass between the 50kD and 75kD 
markers is consistent with previous data, and is consistent with the molecular mass of 
Ero1α which is 55kDa (without glycans). It was concluded that 2G4 does bind to 
Ero1α and that Ero1α was expressed at a detectable level in the HeLa cells. 
The antibody is however in limited supply and is not a commercially available 
product. In order to discover the lowest concentration at which 2G4 is able to provide 
a clear signal for Ero1α, a titration experiment was performed (see Figure 1B). Twenty 
µl of HeLa lysate was loaded into each lane and separated by SDS-PAGE as before 
and immunoblotted using different dilutions of 2G4 from the hybridoma supernatant, 
to investigate the optimum concentration. Lanes 1 and 2 were at a 1:2 dilution, lanes 3 
and 4 at 1:5, lanes 5 and 6 at 1:10, lanes 7 and 8 at 1:50 and finally lanes 9 and 10 at 
1:100. The film was exposed to the samples for 30 seconds. 
As can be seen in Figure 1B lanes 1-8 all show Ero1α staining, whilst lanes 9 and 10 
show no protein detection at all. Lanes 7/8 show the clearest staining, with a small 
specific band as opposed to the somewhat overexposed bands seen on lanes 1-6. At a 
1:2 dilution there is also some level of staining not seen in Figure 1A, suggesting 
either insufficient blocking of the membrane or non-specific binding by the 2G4 
antibody. As the samples were all run and blocked together on the same gel, it is more 
likely that the additional staining is mainly from strong exposure. The lowest 
concentration of 1:100, seen in lanes 9 and 10, showed no detection at all. This would 
suggest that the 2G4 has fallen to a concentration at which is it unable to bind to Ero1α 
in high enough amounts to be detected.   
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Thus from this data, the optimum dilution at which to use the 2G4 antibody for 
detecting Ero1α is at 1:50 as this gives a sharply defined band of marked protein, with 
no background staining.  
As mentioned previously the specificity of the binding of an antibody is important. If it 
binds to more than one protein this must be known if the results are to be correctly 
interpreted. In the case of the 2G4 antibody we need to be sure that it only binds to 
Ero1α and not to any other related proteins such as Ero1β which is also found in some 
cells and tissues.  
To test this, HeLa cells were transfected with either Ero1α mutant C397A-myc (see 
3.1.1 Table 1), Ero1β-HA or a combination of MHCII plasmids (HLA-D, HLA-DM 
and invariant chain) as negative controls. Lysates were prepared from these 
transfectants as described in Chapter 2.5. The lysates were loaded onto a 10% 
resolving gel, separated by SDS-PAGE and immunoblotted with either 2G4 or 9B11, 
an anti-Myc antibody (two separate membranes). 
Figure 2A shows the 2G4 western blot, using the same 1:50 dilution as optimised 
previously in Figure 1. In lanes 1 and 2 where the C397A-myc lysate was loaded a 
single band can be seen between the 75kDa and 50kDa markers, corresponding to 
Ero1α. Lanes 3 and 4 were blank, whilst 5 and 6 showed a very faint band running just 
above the 50kDa marker. 
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Figure 2. 2G4 binds specifically to Ero1α. A, HeLa cell lysates from transfection with 
Ero1α C397A-myc (lanes 1 and 2), Ero1β-HA (lanes 3 and 4) and MHCII (lanes 5 and 6) 
were immunoblotted with 2G4 at 1:50 concentration after separation via SDS-PAGE. 
B, HeLa lysates were run in the same manner as A then immunoblotted with 1:2000 
αMyc 9B11. C, The membrane from B was reprobed with αHA. The arrow β indicates 
the running level of Ero1β in lanes 3 and 4. 
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In Figure 2B the samples were run in the same order and manner as in Figure 2A but 
were instead immunoblotted with 9B11 which binds specifically to the tag sequence 
Myc. As can be seen in Table 1 in section 3.1.1 Ero1α C397A has been tagged with 
Myc whilst the other constructs used in this experiment are not. As such we would 
expect to see bands for the myc-tagged Ero1α mutant running at a similar level to wild 
type Ero1α, and no bands apparent in the other lanes. 
In figure 2B, lanes 1 and 2 both had distinct strong bands corresponding to Ero1α, 
showing that the transfection with the Ero1α C397A construct has been successful and 
the cells in the lysate were producing the mutant variant of Ero1α. This also 
corroborates the previous evidence that 2G4 binds specifically to Ero1α proteins, as 
when the data from Figure 2A and 2B were compared the bands in lane 1 and ran at 
appropriate molecular weights. From this can be concluded that these bands represent 
Ero1α C397A-myc protein and that 2G4 was able to detect the mutant Ero1α as well 
as the wild type, as seen in Figure1. 
As well as the Ero1α bands, lanes 1-4 all showed a band of higher molecular weight, 
running above the level of the C397A signal at approximately 100kDa. This band is 
most probably corresponds to a cross reactive protein recognised by the 9B11 antibody 
leading to these background signals. These bands are however useful as a loading 
control for the lanes 3 and 4. From them we can see that there was indeed protein 
present on the membrane. When combined with the fact that there is no equivalent 
Ero1α band as seen in lanes 1 and 2, we can conclude that the 9B11 antibody 
specifically only binds to the myc-tagged proteins. 
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The membrane used to produce Figure 2B was rehydrated in TBST solution for 1 hour 
before being reprobed with an anti-HA antibody, without prior stripping of the 
previous antibody. The results of this reprobe can be seen in Figure 2C. 
In lanes 1 and 2, the signals seen can be attributed to the 9B11 antibodies still on the 
membrane from the previous immunoblot.  Lanes 3 and 4 also showed a similar 
pattern of additional bands but to a stronger degree than that of lane 1 or 2. Of greater 
note however is the band seen at the level marked by the arrow β. This band ran at a 
lower height than any of the previous experiments. As noted by Dias-Gunasekara et al 
(2005) this lower weight band represents the HA tagged Ero1β protein. The signal was 
more clearly visible in lane 4 than lane 3. 
The data in Figure 2C demonstrates that 2G4 only binds to Ero1α and not the Ero1β. 
The HA blot of Ero1β showed that Ero1β was produced by the transfected cells and so 
would also have been in the lysate samples run in Figure 2A. As there is no band in 
lanes 3 and 4 of Figure 2A we can be sure that 2G4 did not bind to Ero1β or to the 
MHCII proteins, which are involved in antigen presentation and are not related to the 
Ero or PDI families. 
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3.1.3. Detection of Ero1 and Notch proteins by antibody staining 
Western blots were carried out in order to assess the protein expression following 
transfection with various cDNA, as well as the endogenous levels of protein 
expression in non transfected cells. This also served the secondary purpose of 
confirming that the cDNAs expressed the protein expected other second cell lines. 
HEK293 cells were transfected individually with each of the eight constructs detailed 
in Table 1 of 3.1.1 as described in Chapter 2.4.2 and lysed in the presence of lysis 
buffer containing 20mMol NEM as described in Chapter 2. In addition a control dish 
of cells was prepared by treating the dish with the X-tremeGENE (Roche) kit 
according to manufacturer’s instructions without the addition of any cDNA. The 
lysates were loaded onto a 10% resolving gel and transferred to PVDF membranes. In 
all cases the samples were run in the order shown in Table 3 below. 
Table 3 – Constructs used for Western blotting and their respective tags 
Construct Tag 
Human Jagged 1 -- 
Human Notch 1 -- 
Full Length Jagged 1 V5 
NICD-Full length (Inducible) -- 
NICD-Full length (Non-inducible) Myc 
Ero1-α C394A Myc 
Ero1-α C397A Myc 
Ero1-α (Wild Type) -- 
Mock transformation -- 
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Figure 3. Antibody detection of proteins in HEK293 cells. A, HEK293 cell lysates from 
transfection with hJag1 (lane 1), hNotch1 (lane 2), FL-Jag1 (lane 3), NICD-FL1 (lane 4), 
NICD-FLni (lane 5), C394A (lane 6), C397A (lane 7), Ero1α-wt (lane 8) and a HEK293 
mock transfection lysate (lane 9) were separated by SDS-PAGE and immunoblotted 
with αPDI antibody. B, HEK293 cell lysates from transfection with hJag1 (lane 1), 
hNotch1 (lane 2), FL-Jag1 (lane 3) were immunoblotted with C20 antibody or C, with 
αV5 antibody. D, lysates from HEK293 cells transfected with NICD-FL1 (lane 4), NICD-
FLni (lane 5), C394A (lane 6) and C397A (lane 7), were immunoblotted with the αmyc-
tag antibody 9B11. 
 
  Results 
49 
 
Figure 3A shows an immunoblot control probing for PDI. In this experiment universal 
expression of PDI in all lysates was seen as expected. This acted as a control and 
showed that equal amounts of protein had been loaded in the samples and transferred 
from the gel. As seen in Figure 1A of 3.1.1. a doublet was present in all cases with 
PDI being the lower more strongly stained band. This would suggest that the cells 
retained bound albumin. However the transfected HEK293 cells tended to detach 
during additional washing leading to an unacceptable level of cell loss.  
Figure 1B shows staining with C20, a commercially available antibody to Jagged 1. 
Consistent with the manufacturer’s description of this antibody, hJag1 can be seen at a 
running height of 150kD, with a smear seen instead of a defined band. In this blot 
Jagged 1 was detected in lanes 1 and 3, with lane 3 staining more strongly than lane 1 
at a height corresponding to approximately 150kD. These two lanes correspond to the 
cell lysates which had been transfected with the two versions of hJagged1. Lane 2 
showed no detection of any Jagged1 protein as expected since this was a negative 
control for the antibody.  
This experiment suggests that the cDNA constructs for Jag1 were taken up and 
expressed in the cells causing the high level of expression shown in lanes 1 and 3. The 
higher level in lane 3 would imply that either there was a greater transfection 
percentage in cells transfected with FL-hJag1 cDNA or that the construct caused the 
cells to produce a larger amount of Jag1 than the hJag1 construct.  
Figure 1C shows staining with an antibody against the V5 tag. As only the full length 
Jagged 1 construct has been tagged with a V5 tag the expected result was to see 
expression in lane 3 at 150kDa, the molecular mass of Jagged 1. As can be seen this 
was the case. No other lanes showed any V5 staining and there was no other 
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significant background staining. Lack of detection of the hJag1 in lane 1 shows the 
specificity of the antibody to the V5 tag on the Jagged 1 protein in lane 3, not the 
protein itself. Lane 2 is shown as a negative control, confirming that the V5 antibody 
does not bind to Notch. 
Figure 3D shows staining with 9B11, an antibody against the myc tag. Lanes 6 and 7 
showed detection of protein with a molecular mass of approximately 75kDa 
corresponding to the two myc tagged Ero1α mutants, C394A and C397A. It was 
expected to see some detection in lane 5 at approximately 80kDa, the molecular 
weight of the NICD. However no protein was detected, suggesting either a lack of 
expression of the NICD due to low transfection efficiency or levels of NICD in the 
lysates not detectable by the 9B11 antibody. Lane 4 contained NICD-FLi, which was 
not myc-tagged and thus no protein was detected. All lanes showed some non-specific 
binding between the 130kDa and 170kDa markers, most likely corresponding to cross 
reaction of the 9B11 to endogenous proteins. As the myc-tag is derived from the c-
Myc transcription factor this level of background staining can sometimes be expected. 
The results shown in Figure 3 allow two main conclusions to be drawn from the data. 
Firstly, it helps to confirm that the cDNA constructs express the expected proteins, 
with all the lysates from each transfection behaving as expected for each antibody, 
with the exception of the NICD-FLni in Figure 1D. Also the experiments confirmed 
that the transfection worked correctly, with the plasmids being taken up by the cells 
and the proteins of interest expressed. 
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3.1.4.   Location of transfected proteins by immunofluorescence 
Immunofluorescence experiments were carried out in order to localise the expression 
of transfected proteins. Immunofluorescence allows the subcellular location of a 
protein to be visualised within the cell and can be used to assess co-localisation with 
potential partner proteins. Cells were stained with both DAPI, to view the nucleus of 
the cell, and antibodies specific to the protein. The primary antibodies are then reacted 
with fluorescent secondary antibodies which allow the proteins to be viewed under 
either a green or red filter.   
HEK293 cells were grown on coverslips and then mock transfected using the 
lipofectamine protocol before being prepared for immunofluorescence according to 
protocol outlined in 2.9. In this instance the cells were permeabilised with 0.1% 
TX100.  
Under the DAPI filter, the staining of the cell nuclei can be seen. The images on the 
left of Figure 4; a, c, d and e all show the DAPI staining of the cell nuclei. The 
equivalent image to their left; b, d, f and h respectively, show the same coverslip under 
a different relevant filter.  
The coverslip seen in Figure 4a and 1b was stained for PDI with Alexa fluor-488 
secondary anitbody which was then viewed under the relevant filter. The PDI protein 
was resident in the ER of the cell as expected, evidenced by perinuclear staining 
around the nuclei (see labelled arrows x and y for example) corresponding to the 
location of the ER within the cell. 4x and 4y show expanded images of the cells 
visualised to better show the typical ER staining seen. Closer inspection of cell x 
showed the cell to be in the process of mitosis, due to its distinct telophase structure 
and evidence of cleavage furrows, showing the cells were still actively growing and 
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dividing. These strong staining patterns seen in our cells correspond to previous data 
from our group (van Lith et al, 2005) and other comparative sources, so we are 
confident that the staining seen is of PDI in the ER of the cell. 
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Figure 4. Immunofluorescence detection of proteins in HEK293 cells. HEK293 cells 
were probed with DAPI (a) and αPDI (b) and photographed at 20x magnification 
under the according filters. x and y show individual cells stained with αPDI. 
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Figure 4 (continued). Immunofluorescence detection of proteins in HEK293 cells. 
HEK293 cells were probed with DAPI (c, e and g) and either 2G4 (d), αV5 (f) or αMyc 
(h) and photographed under the according filters.  
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In figure 4c/d, the coverslip was probed using 2G4 to localise Ero1α expression within 
the cell. Previous work has shown Ero1α to be resident to the ER, and to co-localise 
with PDI and so expression of Ero1α was expected to be very similar to the PDI 
staining seen in 4b. Figure 4c showed DAPI staining the nuclei as expected. Figure 4d 
showed protein detection in the ER like that seen in 4b, however the level of detection 
was much lower than for PDI and not as widely expressed through the ER. We can see 
by comparing 4c to 4d that not all the cells present have been successfully stained for 
Ero1α. This would suggest that the dilution of the 2G4 used was too low to detect 
Ero1α in all the cells present. Nevertheless the cells which have been successfully 
probed with the antibody show the protein detection pattern that was expected for 
Ero1α. 
The coverslip shown in 4e/f was probed with αV5 antibody in addition to the DAPI 
staining. Figure 4e shows DAPI staining the nuclei as expected. As the V5 antibody 
detects the V5 tag sequence which is not found on endogenous proteins, no protein 
detection was expected. Figure 4f did show some faint staining in the cells which 
seems to correspond to the ER. This was therefore most likely to be non specific cross 
reactions between the αV5 antibody and one or more endogenous proteins located in 
the ER of the cell. This data would suggest that the antibody is either unsuitable for 
use in immunofluoressence or is needed at much higher concentrations to give 
detection of the protein. 
Cells in Figure 4g and 4h were stained with an anti-myc tag antibody at 1:1000 
dilution. The myc tag is a 1202kDa polypeptide protein tag normally fused to either 
the C or N-terminus of a protein. Whilst the cells do express the c-Myc transcription 
factor for which the myc-tag is derived, this should not be detected by the antibody 
used as it is a nuclear protein. Therefore, as the sequence is not normally found in 
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naturally occurring proteins outside of the nucleus, no myc signal was expected as 
seen in Figure 4h. The presence of cells was confirmed by the DAPI nuclear staining 
in 4g, confirming that there were cells present on the coverslip and that no staining has 
occurred on any proteins from the anti-myc antibody as expected. 
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 3.2 Investigations into Ero1α/Notch pathway interactions  
3.2.1 Immunofluorescence of transfected HEK293 cells   
The results from 3.1.4 have shown the base endogenous protein expression in HEK293 
cells. To expand on this, cells were next transfected with cDNA constructs to 
investigate the localisation of the ectopic proteins as well as the transfection 
efficiency. HEK293 cells were grown and then transfected with 1ng of the relevant 
cDNA using the lipofectamine protocol before being prepared for 
immunofluorescence according to protocol outlined in section 2.9. All cells were 
permeabilised with 0.1% TX100.  
Figure 5 shows data from HEK293 cells transfected with wild type Ero1α. In all cases 
the DAPI staining is shown on the left of the row, the antibody staining is central and 
the right hand image is a false colour combination of the other two images to allow for 
comparison. Figure 5 a, b and c shows data from an αPDI detection with Alexa fluor 
488 fluorescent secondary antibody, whereas Figure 5d, e and f used Alexa fluor 594 
secondary antibody. PDI is known to be a marker of the ER, and consistent with 
earlier experiments, PDI is located at the nuclear periphery of the cell. Both false 
colour combinations allowed this to be seen more clearly as the overlay clearly shows 
perinuclear staining against the nuclear localised DAPI stain. The V5 staining shown 
in 5h was again subject to very high background levels. The staining seemed to be 
universal throughtout the cell, not confined to any paticular region. This was in 
contrast to the previous example in Figure 4, where the V5 background was limited to 
the ER. Several atempts were made to visualise Ero1α using 2G4. However the high 
levels of background prevented reliable localisation and co-localisation of 
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endogeneous Ero1α. Also due to the wild type Ero1α used it is impossible to 
differentiate which cells  
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Figure 5. Immunofluorescence detection of proteins in HEK293 cells transfected 
with Ero1α-wt. HEK293 cells were stained with DAPI (a, d and g) and either PDI-G (b), 
PDI-R (e) or αV5 (h) and photographed at 20x magnification under the relevant 
filters. c, false colour combination of a (blue) and b (green). f, false colour 
combination of d (blue) and e (red). i, false colour combination of g (blue) and h 
(green). 
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Figure 6. Immunofluorescence detection of proteins in HEK293 cells transfected 
with C394A Ero1α mutant. HEK293 cells were probed with DAPI (a and b) and either 
αPDI (b) or αMyc (d) and photographed under the according filters. 
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were sucessfully transfected and expressing the ectopic version of the protein using the 
2G4 antibody which will bind to both the ectopic and endogenous version of the 
protein. 
Given that endogenous Ero1α was hard to detect in HEK293 cells, we continued the 
analysis with transfected Ero1α. Figure 6 shows an example of data from transfection 
with the C394A Ero1α mutant. The coverslip for Figure 6a/b was probed with αPDI 
antibody and the coverslip in Figure 6c/d was probed with αMyc antibody. From this 
experiment it was hoped to see the localisation of the myc tagged Ero1α mutant, which 
should be expressed in the ER as with the wild type.  
Figure 6b shows PDI detection in the ER as expected. Figure 6d shows the staining 
with the αMyc antibody, which has detected protein expression in approximately 11% 
of the cells. The active site mutant of Ero1α shows very similar ER localisation to 
previous data from both wild-type Ero1α and PDI. Thus it can be concluded that the 
detected protein is the C394A mutant variant of Ero1α. Whilst the transfection 
efficiency is lower than would be expected for this cell line and protocol, this 
demonstrates that HEK293 cells can express detectable mutant Ero1 proteins. 
Figure 7 shows data from transfection with the hNotch1 cDNA. The coverslip for 
Figure 7a/b was probed with αPDI antibody and the coverslip in Figure 7c/d was 
probed with αMyc antibody as a negative control. From this experiment we were able 
to demonstate the specificity of the myc antibody, which was unable to detect the 
Notch protein. Despite several attempts, we were unable to detect Notch using the 
αNotch antibody which was unsuitable for use by immunofluorescence (data not 
shown). The issues with this antibody in immunofluorescence have also been seen by 
Dr. Ambler’s group. 
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Figure 7. Immunofluorescence detection of proteins in HEK293 cells transfected 
with hNotch1 cDNA. HEK293 cells were probed with DAPI (a and b) and either αPDI 
(b) or αMyc (d) and photographed at 20x magnification. 
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Figure 7a showed PDI localisation that was consistent with earlier experiments, with 
PDI being located in the ER around the nuclei of the cell. Figure 7b showed strong 
PDI staining with clear definition on the ER, which did not overlap with the nuclear 
DAPI staining of the same coverslip in Figure 7a. Figure 7c showed DAPI nuclear 
staining, confirming cells present on the coverslip but Figure 7d was blank, confirming 
that the αMyc antibody is unable to bind to the Notch protein. However, due to a lack 
of any comparative Notch staining, we cannot confirm that the Notch plasmid has 
indeed been taken up and expressed by the cell. Western blot analysis of cell lystates 
would hopefully be able to confirm if the Notch ligand has been taken up. 
Figure 8 shows data from transfection with the NICD-FLni cDNA. The coverslip for 
Figure 8a/b was probed with αPDI antibody and the coverslip in Figure 8c/d was 
probed with αMyc antibody. From this we wished to localise the myc-tagged NICD 
protein and confirm its expression after transfection. 
The staining of the PDI control in Figure 8a/b was consistent with previous data. This 
NICD was expected to move to the ER/nuclear membrane in order to enter the 
nucleus, where it is functional active in the cells. Staining in the nucleus cytoplasm or 
around the nuclear membrane was therefore expected. Whilst the NICD should be able 
to enter the nucleus, the excess amount of protein the cell would hopefully produce 
from the transfection should lead to a build up around the nuclear membrane for 
detection. As can be seen in 8d this localisation is what appeared to occur in the cells. 
The NICD was detected around the very edge of the nuclear membrane and central 
ER. The examples expanded in x and y shows this pattern more clearly. The signal 
localised to a much smaller and more concentrated area around the nucleus than in the 
equivalent PDI staining of the ER. 
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Having demonstrated that the NICD domain of Notch could be transfected into 
HEK293 cells and detected by the myc antibody, we moved on to examine the Notch 
ligand Jagged1. Figure 9 showed the coverslips with cells which have undergone 
transfection with hJagged1. Figure 9a/b shows the PDI control, which shows strong 
nuclear staining in 9a and equivalent PDI staining in the ER in 9b, despite the slightly 
lower cell retention on the slide than would be ideal. Figure 9c shows the DAPI 
staining of the second coverslip which gave strong nuclear detection. Figure 9d shows 
the αV5 image, in which can be seen staining of the ER of the cell. When compared to 
the mock transfection the strong specific staining with V5 compared to the mock 
transfection suggests that the Jagged1 protein is being expressed by these cells and is 
present in the ER. The transfection efficiency was still lower than the 30% usually 
expected for this transfection reagent in HEK293 cells, at only approximately 9%, but 
nevertheless Jagged expression was clearly seen in the transfected cells. 
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Figure 8. Immunofluorescence detection of proteins in HEK293 cells transfected 
with NICD-FLni cDNA. HEK293 cells were probed with DAPI (a and b) and either αPDI 
(b) or αMyc (d) and photographed at 20x magnification under the relevant filters. x 
and y shows expansions of the cells accordingly marked in 4b. 
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Figure 9. Immunofluorescence detection of proteins in HEK293 cells transfected 
with FL-Jagged1 cDNA. HEK293 cells were probed with DAPI (a and b) and either αPDI 
(b) or αV5 (d) and photographed under the according filters. 
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3.2.2. Jagged 1 perforated verses non-perforated cell immunofluorescence 
 The presence of Jagged1 in the ER of transfected cells in 3.2.1 caused us to question 
whether there is a potential interaction between Jagged 1 and Ero1α in addition to the 
Notch1-Ero1α interaction noted in the Tien paper (Tien et al, 2008). 
In order to study this potential interaction we needed to study further the behaviour of 
Jagged 1 in our cell lines. Using a combination of immunofluorescence and Western 
blots we should be able to distinguish where in the secretory pathway Jagged is 
expressed and whether it interacts with Ero1α or other components of the oxidative 
folding machinery in the ER. 
In order to probe the expression of Jagged1 in the transfected HEK293 cells we 
devised a new experiment.  Jagged 1 is a transmembrane protein normally found on 
the plasma membrane of a cell. Thus cells were prepared for immunofluorescence with 
and without permeabilisation by TX100.  Thus if the Jagged 1 was being expressed by 
the cells and trafficked properly to the cell surface it would be detected there by the 
αV5 antibody in non-permeabilised cells. Control tests were also performed using 
αPDI and 2G4 as controls, in which the permeabilised cells should show ER 
localisation and the non-permeabilised cells would show no staining, as the antibodies 
were unable to enter the cell to bind to the ER resident proteins which they were 
targeting.  
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Figure 10. Immunofluorescence detection of PDI proteins in HEK293 cells 
transfected with FL-Jag1. HEK293 cells were probed with DAPI (a and d) and either 
αPDI with Alexa-fluor 488 [PDI-G] (b) or αPDI with Alexa fluor 610 [PDI-R] (e) and 
photographed at 20x magnification under the appropriate filters. c, false colour 
combination of a (blue) and b (green). f, false colour combination of d (blue) and e 
(red).  
 
 
 
  Results 
69 
 
HEK293 cells were transfected with the FL-Jag1 construct or the Ero1α construct 
using the lipofectamine transfection method and prepared for immunofluorescence 
according to the protocol outlined in 2.9. Depending on the sample in question, the 
cells were either permeabilised with 1% TX100 solution or the permeabilisation step 
was omitted. Non-permeabilised samples were kept in PBS++ buffer whilst the other 
samples were undergoing permeabilisation treatment before continuing with the 
protocol as detailed in section 2.9.  
Figure 10a, b, c, d, e and f show the cells probed with DAPI and αPDI with either 
Alexa fluor 488 or 610. As seen previously, the PDI staining (Figure 10b and e) 
corresponds to the ER, which could be seen to lay around the nuclei (Figure 10a and c) 
of the cells in the false colour images overlays in 10c and 10f. Non permeabilised cells 
were also exposed to the αPDI antibody to act as a control for the cell membrane 
staining, and did not give a specific ER staining pattern, as expected (data not shown).  
The result from the Ero1α localisation in both permeabilised and non-permeabilised 
HEK293 cells are shown in Figure 11. Figure 11a shows the DAPI staining of the 
nuclei of the cells which were permeabilised, and corresponds to the 2G4 staining in 
Figure 11b. Figure 11c is a false colour overlay of both Figure 11a and Figure 11b in 
order to co-localise nucleus and ER. As was previously noted the 2G4 antibody binds 
to Ero1α, and this has occurred in approximately 20% of the cells shown. Figure 11d 
and 11e show the 2G4 probe for the non permeabilised HEK293 cells. The DAPI 
staining in Figure 11d has occurred as expected showing the cell nuclei, as the DAPI 
stain is able to pass freely into the cell through the cell membrane without 
permeabilisation. No 2G4 detection of Ero1α was seen in Figure 11e as was expected. 
Ero1α is a resident protein to the ER and is not seen at the cell surface. Thus with no 
means  
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Figure 11. Immunofluorescence detection of Ero1α proteins in HEK293 cells 
transfected with FL-Jag1. HEK293 cells were probed with DAPI (a and d) and 2G4 (b 
and e) and photographed at 20x magnification. c, false colour combination of a (blue) 
and b (green). 
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of entering the cell, the 2G4 antibody (see earlier sections) was unable to bind to the 
Ero1α and thus is simply removed from the cells during the wash steps.  
Figure 12 shows the HEK293 cells which were permeabilised and then probed with 
αV5 in order to detect Jagged 1 expression within the cell.  As seen before, the V5 
tagged Jag is not apparent in all cells showing approximately 10% transfection 
efficiency. As was seen in 3.2.1 the V5 tagged detection of the Jagged 1 is higher than 
the background levels seen in the untransfected HEK293 cells. The V5 detection was 
centred on the ER of the cell just around the area of DAPI nuclear staining, seen well 
in the merged images. Images were also taken of this at 40x magnification (see Figure 
12 c, d and e) which allowed clear localisation of the Jagged 1 to the ER of the cell. 
The region marked x in 3f is expanded 3x to allow the ER localisation to be seen 
clearly. 
Figure 13 shows the data collected from the HEK293 cells which were not 
permeabilised and then probed for expression of Jagged1 at the cell surface. Figure 
13a, b and c were taken at 20x magnification and the data showed the V5 tagged 
protein expressed at the cell surface, as can most clearly seen in Figure 13c. Here the 
Jagged1 is seen surrounding but not in contact with the area around the cell nuclei 
suggesting that it is being presented at the cell surface. This can be more clearly seen 
in Figure 13d-i at 40x magnification. This data showed the Jagged1 presented at the 
cell membrane, and several good examples can be seen expanded in Figure 13x,y and 
z. Co-localisation with another cell membrane protein to confirm localisation was not 
possible due to time and resource constraints 
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Figure 12. Immunofluorescence detection of Jag1 proteins in HEK293 cells 
transfected with FL-Jag1. HEK293 cells were probed with DAPI (a and d) and αV5 (b 
and e) and photographed at 20x magnification under the according filters. c, false 
colour combination of a (blue) and b (green). f, false colour combination of d (blue) 
and e (green). x, expansion of the area marked in 3f.   
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Figure 13. Immunofluorescence detection of Jag1 proteins in non permeabilised 
HEK293 cells transfected with FL-Jag1. HEK293 cells were probed with DAPI (a, d and 
g) and αV5 (b, e and h) and photographed at 20x magnification under the according 
filters. c, false colour combination of a (blue) and b (green). f, false colour 
combination of d (blue) and e (green). i, false colour combination of g (blue) and h 
(green). Cells marked in 4f and i are expanded in x, y and z. 
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In conclusion, the data suggests that not only is Jagged1 being expressed in some of 
the cells, but that it is being fully processed as it would be in vivo and then transported 
to the cell surface where it is being presented on the plasma membrane, as it normally 
would be to undertake its normal function in Notch signalling. The data shown in both 
Figure 12 and 13 shows us that Jagged1 is being expressed in some of the cells, but 
not all in both cases. The fact that the staining is better on the non permeabilised cells 
may be due to the antibody being able to bind to the jagged better when it is properly 
presented at the cell membrane, possibly due the difference in the shape or 
presentation of the binding region to the antibody or it is easier for the antibody to 
bind at the surface than to infiltrate the cell and bind to the Jagged1 in the ER. 
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3.2.3  Co-immunoprecipitation studies with Ero1α and Notch pathway proteins 
Immunoprecipitation is a technique used to isolate individual proteins from cell lysates 
by the use of antibodies which specifically bind to the protein of interest. Antibodies 
are bound to a solid substrate such as sepharose beads preloaded with protein A or G 
which bind to the heavy chains of the antibody.   
Co-immunoprecipitation was used on lysates in order to pull down a known protein 
and investigate other proteins to which it might be bound within the cell. Co-
immunoprecipitation of protein complexes can help to elucidate novel members of 
protein networks and reveal new protein interactions. Initially we wanted to look into 
the potential interaction between Ero1α and Notch1 in mammalian cells. However, the 
lack of a suitable Notch antibody limited this approach. Instead we investigated if 
there was an interaction between Ero1α and Jagged1, as the previous 
immunofluorescence data had shown that both could be expressed in the HEK293 cell 
line. Jagged also has the most similar structure to Notch of the proteins available to 
test, with both EGF repeats and an area of cysteine residues similar to the LNR region 
of Notch which is where Ero1α may bind to Notch. As such it is also possible that 
Ero1 may bind to this cysteine rich region of Jagged to aid in disulphide bond 
formation. If shown to be true this would elucidate a potentially new folding client for 
the Ero1α-PDI pathway as well as further expanding our knowledge of Notch biology. 
The first experiment undertook was to see if 2G4 was able to detect Ero1α pull down 
by PDI. Protein A beads were incubated with αPDI antibody as described in 2.6 and 
then 50µl of beads were added to either HeLa or HEK293 lysates which had been 
transfected using Ero1α C394A, Ero1α C397A, Jagged1 or Jagged 1 with Ero1α 
  Results 
76 
 
C974A as well as a mock for control. The original lysates as well as the IPs were then 
separated by SDS-PAGE and visualised. 
Figure 14a shows the results of the HeLa lysates and PDI-IPs, blotted for with 2G4. 
The lysates all showed detection of Ero1α concordant with previous results. The mock 
transfected lysate in lane 1 shows lower detection of Ero1α, whereas the lysates in 
lanes 2 and 3 show stronger Ero1α detection. The higher protein level showed that the 
transfection had been successful and the cells were expressing the mutant version of 
Ero1α.  Interestingly, the lysate transfected with Jagged 1 in lane 4 also showed higher 
levels of Ero1α detection. This would imply that the increased levels of Jagged 1 in the 
cell were causing an increased level of Ero1α production in the cell. Lane 5 contained 
the lysate transfected with both Ero1α C974A and Jagged 1. As such the increased 
detection of Ero1α seen, when compared to the mock transfectant in lane 1, either 
means that the cells were producing the mutant  version of Ero1α or that the Jagged 1 
production was affecting the cells Ero1α levels as in lane 4. Another possibility is that 
the different detection levels are not cause by differences in protein levels but is from a 
transfer or detection issue from the gel. If this is the case a re-run of the gel should be 
able to prove which of the two ideas is correct. 
 The IPs in figure 14a did not show any detection of Ero1α. This either means the IP 
was unsuccessful in pulling down any of the protein or that the levels of protein pulled 
down were unable to be detected. Following up this experiment by either re-blotting 
the gel with anti-myc antibody to see if the myc tagged versions of Ero1α are 
detectable or by using a higher 2G4 concentration to attempt to get a greater sensitivity 
of detection would possibly provide more data as to what has occurred. The low 
weight bands seen in each lane are most likely to be from cross reactivity of the 
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antibody light chains, but this signal is normally much weaker. Also the antibody 
heavy chains normally seen at 50kDa are not seen 
Figure 14b shows the data from the HEK293 cells. The lysates in lanes 1-5, showed 
detection levels of Ero1α in line with what was seen in 14a, albeit at slightly lower 
overall levels than seen in the HeLa cells. The HEK293 IPs again showed no Ero1 
detection but did show detection of the antibody heavy chains at around 50kDa which 
were not seen in Figure 14a. Lane 11 showed a very faint detection of protein at the 
level at which Ero1α is normally seen. This suggested that the IPs were in fact 
working but that they were just pulling down very low levels of Ero1α or that Jagged 
is inducing a slight increase in the levels of Ero1 produced in the cell. Again, a re-blot 
using a higher concentration of 2G4 may allow better detection of any Ero1α proteins 
that are present. 
Since none of the previous immunoprecipitations had been able to detect Ero1α a 
second experiment was performed. IPs were carried out on lysates of HeLa and 
HEK293 cells, both transfected with Ero1α C974A, and this time using 100µl of 
Protein A beads which had been incubated with αPDI antibody, in an attempt to pull 
down more proteins for detection. As can be seen in Figure 14c, both lysates IPs now 
showed detection of Ero1α when using the higher levels of beads. This would suggest 
that the previous conclusions that the levels of protein pulled down in Figures 14a and 
b were too low to be detected. 
Together this data confirms that the immunoprecipitations were successful and that 
PDI and Ero1α complex together in the cell as shown in previous published work.  
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Figure 14. Detection of Ero1α from immunoprecipitations of cell lysates using αPDI 
antibodies bound to protein A beads. A, HeLa cell lysates from transfection with 
Ero1α C394A (lane 2), Ero1α C397A (lane 3), Jagged1 (lane 4), Jagged 1 with Ero1α 
C974A (lane 5) or mock transfected (lane 1) as well as immunoprecipitations using 
αPDI bound to Protein A beads with the lysates, Ero1α C394A (lane 7), Ero1α C397A 
(lane 8), Jagged1 (lane 9), Jagged 1 with Ero1α C974A (lane 10) or mock transfected 
(lane 11) were immunoblotted with 2G4 at 1:50 concentration after separation via 
SDS-PAGE. Lane 6 is blank. B, As described in A instead using HEK293 cells. C, Lysates 
from HeLa cells (lane 1) and HEK293 cells (lane 2) were transfected with Ero1α C974A 
and immunoprecipitated using 100µl of αPDI bound to Protein A beads before 
immunoblotting with 2G4 at 1:50 concentration after separation by SDS-PAGE. 
 
 
 
  Results 
79 
 
Figure 15 shows the results for the immunoprecipitation experiments investigating 
whether Ero1α can successfully pull down the V5 tagged Jagged1 and vice versa. Due 
to the higher levels of detection seen in 14c HEK293 cells were used. Figure 15a 
shows the results from an IPs with either V5 or 2G4 bound to 100µl of protein A 
sepharose beads which was then blotted back with 2G4 and 15b shows the equivalent 
samples blotted back with αV5 antibody.  
Figure 15a shows the immunoprecipitation of Jagged 1 transfected HEK293 cells with 
either 100µl of protein A beads incubated with αV5 antibody (lane 1) or 2G4 (lane 2). 
Lane 2 showed Ero1α detection from the lysate which is what was expected from the 
previous data gathered. Lane 1 showed a detection of Ero1α from a pull down with the 
αV5 antibody. This suggests a potentially novel interaction, that Jagged 1 forms a 
complex with Ero1α within the cell.  
Figure 15b shows the reciprocal interaction to what was seen in Figure 15a. Lane 2 
shows the result of Ero1α pull down via the 2G4 antibody, with the V5 antibody 
detecting Jagged 1 as seen in previous experiments. This suggests that Ero1α is also 
able to pull down Jagged 1, strengthening the conclusion from Figure 15a that the two 
proteins form a complex with each other. The result from lane 1 was unexpected as a 
similar Jagged 1 signal to that seen in lane 6 was anticipated. The lower weight protein 
band detected between 75kDa and 50kDa is likely to be cross-reactive antibody heavy 
chains. 
This data shows that in immunoprecipitation Ero1α was able to retrieve Jagged 1 and 
that the opposite was also true, with Jagged 1 pulling down Ero1α as well. This 
suggests a novel interaction between these two proteins, suggesting that Ero1α may 
have a role in the folding of Jagged1. 
  Results 
80 
 
 
 
 
 
 
Figure 15. Jagged 1 and Ero1α form a complex within the cell. A, HEK293 lysates 
were transfected with Jagged 1 and immunoprecipitated with either αV5 (lane 8) or 
2G4 (lane 9) antibodies bound to protein sepharose A beads, then immunoblotted 
with 2G4 at 1:50 concentration after separation by SDS-PAGE. B, HEK293 lysates were 
transfected with Jagged 1 and immunoprecipitated with either αV5 (lane 8) or 2G4 
(lane 9) antibodies bound to protein sepharose A beads, then immunoblotted with 
αV5 after separation by SDS-PAGE 
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 4.  Discussion 
4.1 Characterisation of cDNA and ectopic proteins 
Ectopic expression of proteins via cDNA plasmids is a highly useful tool in biology, 
used to analyse a huge variety of factors such as the effects of a proteins expression on 
a cell, its localisation, interactions and its effects on both a cellular and whole 
organism level. In this several cDNA plasmids were studied and the proteins they 
produce within cells. This will be of further use to the group in any future work into 
this area.  
The Ero1α plasmids, Ero1α-wt, C394A and C397A, had been previously described 
and used by the group and the results for localisation in immunofluorescence (Chapter 
3.2.1) and antibody detection with Western blotting (Chapter 3.1.3) was concordant 
with this data. The proteins were all detected by the Ero1α specific 2G4 antibody and 
the two mutant myc tagged versions of Ero1α were detectable with an anti-myc tag 
antibody (Chapter 3.1.3 Figure 3D). Localisation of all the Ero1α proteins to the ER 
was also as expected. 
The two Jagged 1 plasmids and the encoded Jagged 1 protein, one V5 tagged the other 
not, were also successfully tested. Both the wild type human Jagged 1 and V5-tagged 
version, were detectable in immunoblotting with the C20 anti-Jagged 1 antibody 
(Chapter 3.1.3 Figure 3B) and only the V5-tagged Jagged protein was detectable with 
an anti-V5 antibody (Chapter 3.1.3 Figure 3C). In immunofluorescence studies 
(Chapter 3.2.1) due to constraints on stocks of the C20 antibody, only the V5-tagged 
version of Jagged 1 was used. Localisation in permeabilised cells was shown to place 
the Jagged 1 in the ER of the cell, with levels of detection higher than the background 
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levels of V5 staining in the mock transfected cells (Chapter 3.1.4). Non-permeabilised 
cells were used to see if there was any presentation of V5 tagged Jagged at the cell 
surface which was clearly seen (Chapter 3.2.2). Together this data allowed us to see 
that the Jagged 1 protein was being expressed by the cells, and that it is localised to the 
ER of the cell before being presented at the cell membrane. 
Some problems were met when trying to confirm the identity of the Notch 1 plasmid 
and protein. Using anti-Notch 1 antibody from Dr. Carrie Ambler’s group, no 
detection could be seen in either immunoblotting or immunofluorescence. As such it 
was not possible to confirm either the identity of the protein produced by the plasmid 
or indeed if there was any transcription of the protein at all. Whilst each experiment 
was attempted several times to try and optimise the protocol, no positive result was 
obtained. Personal communication with Dr. Ambler’s group confirmed that they had 
also been having similar problems with the antibody. If more time had been available, 
commercially available antibodies could be investigated to continue the experiments in 
this area. Another alternative would have been to engineer the available Notch plasmid 
to give various tagged full length and domain Notch mutants. 
The NICD domain of Notch presented some issues with confirmation of identity and 
localisation. No antibody against the active form of the Notch receptor was available 
and so no direct detection experiments could be carried out on both NICD 
plasmids/proteins. The non-inducible form of the protein was tagged with a myc 
sequence and this was instead used to identify this protein. In immunoblots (Chapter 
3.1.3) the myc tag on FL-NICDni could not be detected in transfected lysates. 
However, immunofluorescence localisation experiments (Chapter 3.2.1) allowed the 
detection of the protein around the ER of the cell, close to the nuclear membrane. As 
stated previously the NICD is the active form of the Notch receptor and moves to the 
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cell nucleus to alter transcription patterns within the cell (Schweisguth, 2004). Thus 
the excess of myc-tagged NICD seen at the nuclear boundary was expected and taken 
as confirmation of the NICD protein identity. 
 
4.2 Characterisation of monoclonal anti-Ero1α antibody 2G4 
Antibodies are highly useful tools for detecting proteins in immunoblots, 
immunofluorescence and immunoprecipitation studies. Here we have confirmed and 
extended the range of cell lines and conditions for the 2G4 antibody. 
The 2G4 antibody recognised Ero1α in cell lysates of both transfected and non-
transfected cell lines (Chapter 3.1.2) and was able to pull down Ero1α by 
immunoprecipitation (Chapter 3.2.3). The antibody was also able to localise Ero1α-wt 
and mutant Ero1α-C394A and Ero1α-C397A, dominant negative mutants used for 
controls in later experiments, in immunofluorescence studies (Chapter 3.1.4 and 
3.2.1). This allowed us to isolate and detect Ero1α in this study and will also allow it 
to be used for any further work. In addition, we were able to confirm that 2G4 does not 
cross react with Ero1β proteins (Chapter 3.1.2 Figure 2) which is important to note as 
Ero1α and Ero1β potentially share some epitopes yet have differing functions and 
expression patterns within organisms.  
 
4.3 Interaction between Jag1 and Ero1 
After seeing that Jagged 1 was localised to the ER in permeabilised cells (Chapter 
3.2.1) the possibility of an interaction between Jagged 1 and Ero1α was further 
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investigated. First we confirmed that the 2G4 antibody was capable of pulling down 
Ero1α and that Ero1α co-immunoprecipitated using PDI controls (3.2.3 Figure 14).  
Next we used 2G4 and anti-V5 antibodies to immunoprecipitate Ero1α and Jagged 1 
from lysates transfected with V5-tagged Jagged 1. We saw that Ero1α was able to 
retrieve Jagged 1 and that the opposite was also true, with Jagged 1 pulling down 
Ero1α as well.  This data would imply that we have found a previously uncategorised 
interaction between these two proteins. Jagged 1 contains a cysteine rich region in its 
structure at the base of the extracellular region (see diagram on page 20), and it is 
likely candidate for where Ero1 may bind to Jagged in order to facilitate disulphide 
bond formation. In addition to this the DSL region of Jagged 1 is also rich in 
disulphides required for Notch trans-activation or cis-inhibition (Cordle et al, 2008) 
and has a highly conserved structure required for notch binding. In the same way that 
Ero1 has been shown to be necessary for the function of the LNR region of Notch, 
Ero1 may be similarly needed for the correct formation of the disulphide bonds in the 
DSL region. If this is true then Ero1 may have a much wider role in ensuring the 
functionality of Notch signalling than previously thought, as the DSL region is present 
in all Notch ligands and is evolutionarily conserved across all studied species. Despite 
this, further work into this interaction is needed before any firm conclusions as to its 
biological significance can be made.  
 
4.4 Future directions 
Whilst this study has brought to light a potentially new protein interaction, it has raised 
still more questions to be further investigated. We were unable to successfully 
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demonstrate whether Ero1α and Notch 1 interact in mammalian cells and the novel 
interaction between Ero1α and Jagged 1 warrants further testing and exploration. 
Firstly, we would need to acquire and rigorously test antibodies against both the Notch 
1 receptor and the active NICD using immunoblotting, immunoprecipitation and 
immunofluorescence. With these antibodies we could build on the work started in this 
thesis, using immunofluorescence and immunoprecipitation to investigate if Notch 1 
and Ero1α interact and co-localise, in the same manner as was used to elucidate the 
interaction between Jagged 1 and Ero1α. 
The interaction between Ero1α and Jagged also needs further testing. Confirmation of 
the interaction could be obtained using further immunoprecipitation experiments, 
perhaps coupled with metabolic labelled and pulse chase. This would enable us to see 
whether the interaction occurred during the synthesis and folding of Jagged 1. Such 
experiments would also enable us to test whether post-translational modifications and 
hence maturation of Jagged I is under the control of Ero1a. Control experiments using 
transfection of the dominant negative mutants of Ero1 could also be used to determine 
whether the oxidoreductase activity of the protein is required for oxidative folding of 
Jagged proteins. Similar experiments could be conducted with PDI and its active site 
mutants to see whether any functional effects on Jagged required PDI activity. This 
would be of interest, because there are no examples in the literature of direct Ero1-
client interactions being involved in quality control: the literature shows that Ero1a 
passes disulphides to clients via PDI. Thus another alternative is that Ero1a targets 
overexpressed or misfolded Jagged 1 to the ERAD system for degradation. This could 
be tested by determining whether Ero1a expression influences the half-life of Jagged 1 
in pulse chase experiments. Use of different antibodies such as C20 or other 
commercially available antibodies against Jagged and the use of differently tagged 
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Ero1 proteins would affirm the results seen in Chapter 3.2.2. These experiments could 
also be carried out with other DSL containing proteins such as Jagged2, Delta, Delta-
like 1 or Apx-1 to see if Ero1 is required for DSL formation in all these proteins. 
The relationship between Ero1α, Notch and its clients could be investigated further 
using quantitative real time PCR. Using this technique we could test whether over-
expression of Notch 1 leads to the induction of Ero1α/β and vica versa. Knock down 
experiments using siRNA could also serve a similar purpose, to see what the effects on 
Notch 1 production within the cell are when Ero1α/β are removed. 
Biochemical assays could be preformed to look into the protein-protein interactions 
further. As described by Tien et al (Tien et al, 2008), the secretion efficiency of the 
different domains of the Notch or Jagged proteins, such as the LRNs or EGF-repeats 
can be measured. The domains can be tagged for detection in cell lines and then the 
efficiency of the secretion measured when Ero1α is manipulated within the cell. 
Should the secretion levels drop when Ero1α is reduced or knocked out it would be 
apparent that Ero1α is required for successful folding of the protein and secretion from 
the cell. Tien et al (Tien et al, 2008) suggested that in Drosophila, Ero1α was needed 
for a specific role in disulphide bridge formation of the LNR, and had a more general 
role in that of the EGF domains and a similar effect might also be seen in mammalian 
cells. To see if loss of Ero1α specifically affects disulphide bridge formation in either 
the LNR or EGF domains a trapping experiment can be performed, using a thiol 
conjugating reagent such as AMS. If there are extra free thiol groups on cysteine 
residues of the client domains due to lack of Ero1α, the reagent could bind to these 
thiol groups and increase the molecular mass of the protein by a set amount for each 
thiol group. This change in mass can then be detected in Western blot analysis. 
  Discussion 
87 
 
The relationship between Notch and the Jagged protein could also be further looked 
into in the presence or absence of Ero1α or Ero1β, repeating some of the previous 
experiments using other variants of Jagged to see if they also form complexes with 
Ero1α. If these experiments show promise, one could investigate which disulphide 
bonds in Jagged are targeted by Ero/PDI by using mutant versions of Jagged where the 
bonds are disrupted by site directed mutagenesis give more insight into any potential 
binding of Jagged to Ero1α. 
 
4.5 Concluding remarks 
As well as characterising several antibodies not before used by the group, this thesis 
has laid the groundwork for investigating an entirely novel interaction between Ero1α 
and Jagged 1. Whilst constrains on time have not allowed a full analysis of this 
interaction, together the data collected has provided the opportunity for a great deal of 
further experimentation which could lead to new insights into both the action of Ero1α 
in the cell and the control and processing of the Notch pathway proteins.  
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